ASRM 2007 Annual Meeting

Posters

Please note that all abstracts have been printed in the Final Program as they were submitted to ASRM. Only apparent misspellings have been corrected.

Wine and Cheese Reception
Hall E • Washington Convention Center
ASRM invites you to meet the poster presenters Monday and Tuesday evenings from 5:30 pm-7:00 pm and enjoy a sampling of delicious wines and cheeses. Presenters of posters P-1 through P-448 will be present Monday evening. Presenters of posters P-449 through P-886 will be present Tuesday evening. Supported by Organon USA Inc.

Please note that on Monday, posters will be open from noon until 7:00 pm. On Tuesday, posters will be open from 9:30 am until 7:00 pm. On Wednesday, posters will be open from 9:30 am until 12:00 pm. ASRM cannot be responsible for removing and/or returning posters. All posters not removed by 2:00 pm Wednesday will be discarded.

Back to the Top

MONDAY, OCT. 15, 2007 

ART - IN VITRO FERTILIZATION 

P-1 
A GLIMPSE INSIDE THE IMPLANTATION WINDOW, USING DONOR EGGS. 
M. A. Mainigi, T. A. Molinaro, R. Marunich, C. Coutifaris, K. T. Barnhart. 
(In-Training Award for Research) 

P-2 
COMPARISON OF THE PREGNANCY RATE BETWEEN DAY 6 BLASTO­CYST TRANSFER AND CRYOPRESERVED DAY 6 BLASTOCYSTS TRANSFERRED ON DAY 5. 
H. Motoyama, A. Yanaihara, S. Monzen, T. Yorimitsu, H. Watanabe, T. Kawamura. 

P-3 
ANALYSIS OF SPERM MOTILITY AND FERTILIZATION RATES AFTER THE SEPARATION BY MICROFLUIDIC SPERM SORTER MADE OF QUARTZ. 
D. Shibata, H. Ando, A. Iwase, T. Harata, F. Kikkawa, K. Naruse. 

P-4 
MYTH AND REALITY OF MALE FACTOR INFERTILITY (MFI). DOES IT EXPLAIN WORLDWIDE ICSI RISING? 
Y. Sheynkin, D. Kenigsberg. 

P-5 
HISTORY OF SPONTANEOUS ABORTION INCREASES THE RISK OF OOCYTE DONATION PREG­NANCY LOSS. 
M. J. Miller, F. Licciardi, J. Grifo, A. S. Berkeley, N. Noyes. 

P-6 
CUMULATIVE EMBRYO SCORE AS A PREDICTIVE FACTOR FOR MULTIPLE PREGNANCY AFTER CONTROLLED OVARIAN HYPER­STIMULATION IN IN VITRO FERTILIZATION AND EMBRYO TRANSFER. 
K. A. Pak, S. H. Kim, Y. J. Kim, C. S. Suh, Y. M. Choi, S. Y. Moon. 

P-7 
PRESENCE OF A CYTOPLASMIC HALO AND COMPLETE NUCLEOLAR ALIGNMENT IS PREDICTIVE OF IMPLANTATION RATES AND PREGNANCY RATES FOR PATIENTS 35-39 YEARS OLD BUT NOT FOR PATIENTS LESS THAN 35. 
R. P. Gada, D. L. Walker, K. M. Barud, T. M. Galanits, C. C. Coddington, D.Morbeck. 

P-8 
GnRH-AGONIST VERSUS GNRH­ANTAGONIST IN ELECTIVE SINGLE BLASTOCYST TRANSFER IVF CYCLES. 
E. G. Papanikolaou, W. Verpoest, H. Fatemi, H. Tournaye, A. Vansteirteghem, P. Devroey. 

P-9 
MATERNAL AND PERINATAL OUTCOMES IN ASSISTED REPRODUCTIVE TECHNOLOGY (ART) SINGLETON AND TWIN PREGNANCIES STRATIFIED BY INCREASING MATERNAL AGE. 
E. Chinea, J. Hernandez, V. Sanabria, L. Gonzalez, F. Martin-Casañas, A. Palumbo. 

P-10 
REANALYSIS OF VAGINAL PROGESTERONE AS LUTEAL PHASE SUPPORT (LPS) IN ASSIST­ED REPRODUCTION (ART) CYCLES. 
P. W. Zarutskie, J. A. Phillips. 

P-11 
THE EFFECT OF THE EMBRYOLOGIST/TECHNICIAN ON FERTIL­IZATION RATE AND EMBRYO QUALITY FOLLOWING ICSI AND PREGNANCY RATE FOLLOWING EMBRYO TRANSFER PROCEDURES. 
B. Balaban, A. Isiklar, B. Ata, K. Yakin, B. Urman. 

P-12 
CLINICAL USE OF DAY 6 BLASTOCYSTS. 
H. Watanabe, A. Yanaihara, S. Monzen, T. Yorimitsu, H. Motoyama, T. Kawamura.

P-13 
A NEGATIVE CORRELATION IDENTIFIED BETWEEN PATERNAL AGE AND ART OUTCOME: IS THERE A MALE BIOLOGICAL CLOCK TICKING? 
M. Luna, J. Barritt, N. Bar-Chama, A. B. Copperman, T. Mukherjee, L. Grunfeld. 

P-14 
FAST DAY 3 EMBRYOS OFTEN RESULT IN HIGH QUALITY BLASTOCYSTS AND LIVEBORNS IN AN ART PROGRAM. 
M. Luna, F. Poleshchuk, M. Duke, A. B. Copperman, B. Sandler, J. Barritt. 

P-15 
PROSPECTIVE RANDOMIZED STUDY TO COMPARE FROZEN­THAWED EMBRYO TRANSFER CYCLES OUTCOME IN WOMEN WITH FUNCTIONING OVARIES AND HRT FOR ENDOMETRIUM PREPARATION WITH OR WITH­OUT PRIOR GNRHA SUPPRES­SION. 
J. Ramos, C. Caligara, A. Tocino, I. Rodríguez, F. Carranza, M. Fernández­Sánchez. 

P-16 
COMPARISON OF IMPLANTATION RATES OF SIBLING EMBRYOS DERIVED FROM INTRACYTOPLASMIC SPERM INJECTION (ICSI) OR CONVENTIONAL INSEMINATION (IVF). 
T. H. Taylor, G. Wright, L. F. Colturato, S. Jones-Colon, H. I. Kort, Z. P. Nagy. 

P-17 
BIRTH DEFECTS OF 1397 NEW­BORN CONCEIVED BY IN VITRO FERTILIZATION/INTRACYTOPLASMIC SPERM INJECTION AND EMBRYO TRANSFER. 
S. Chen, L. Sun, S. Li, M. Yin, X. Xiong, J. He. 

P-18 
THE INCIDENCE OF MONOZY­GOTIC PREGNANCIES AFTER EXTENDED EMBRYO CULTURE DIMINISHES AS LABORATORY EXPERIENCE WITH THE TECH­NIQUE INCREASES. 
J. Barritt, M. Luna, M. Duke, B.Sandler, L. Grunfeld, A. B. Copperman. 

P-19 
PURE FSH VERSUS FSH + HMG STIMULATION IN IN VITRO FER­TILIZATION (IVF) CYCLES: WHICH YIELDS BETTER OUTCOMES IN BLASTOCYST TRANSFER CYCLES? 
J. Q. Huang, S. Shastri, E. Barbieri, S.D. Spandorfer, Z. Rosenwaks. 

P-20 
DOES POST FIXED NUCLEI MORPHOLOGY PREDICT THE OUTCOME OF PREIMPLANTATION GENETIC DIAGNOSIS-ANEUPLOID SCREENING? 
N. L. Buehler, C. Briton-Jones, M. Surrey, H. Danzer, D. L. Hill. 

P-21 
TREATMENT OF MILD/MODERATE MALE FACTOR INFERTILITY WITH IN VITRO FERTILIZATION (IVF) INSTEAD OF INTRACYTO­PLASMIC SPERM INJECTION (ICSI): A TEN-YEAR RETROSPEC­TIVE ANALYSIS. 
L. K. Smith, J. L. Phy, M. J. Odom Dorsett. 

P-22 
PRESENCE OF BLOOD IN THE TRANSFER CATHETER DOES NOT AFFECT IMPLANTATION OR CLINICAL PREGNANCY RATES WHEN USING THE 'AFTERLOAD' METHOD OF ET. 
B. J. Stegmann, F. W. Larsen, A. DeCherney, J. Segars. 

P-23 
SIMPLE PRONUCLEAR ANALYSIS: RELATION TO EMBRYO CLEAVAGE ON DAY 3. 
J. R. Alegretti, A. M. Rocha, J. Fioravanti, M. Ribeiro, E. Motta, P. Serafini. 

P-24 
PERINATAL MORBIDITY AND IN VITRO FERTILIZATION (IVF): DOES FRESH VERSUS FROZEN EMBRYO TRANSFER MATTER? 
S. Kansal Kalra, S. J. Ratcliffe, L. Weissmann, C. R. Gracia, C. Coutifaris, K. T. Barnhart. 

P-25 
IMPLICATIONS OF THE FAS/FAS LIGAND SYSTEM REGULATING APOPTOSIS IN FOLLICLES UNDER COASTING. 
J. A. Garcia-Velasco, G. Quea, S. Rabadan, A. Pacheco, A. Requena. 

P-26 
LEUPROLIDE ACETATE TRIGGER EFFECTIVELY PREVENTS OVARIAN HYPERSTIMULATION SYN­DROME (OHSS) WITHOUT COMPROMISING CLINICAL OUTCOMES IN PATIENTS WITH SERUM ESTRADIOL (E2) >4,000 PG/ML IN IVF CYCLES. 
A. J. DiLuigi, L. Engmann, L. J.Siano, D. B. Maier, J. C. Nulsen, C. A. Benadiva. 

P-27 
CORRELATIVE FACTORS ON MULTIPLE GESTATION AND PREGNANCY IN IN VITRO FERTILIZATION AND EMBRYO TRANSFER. 
S. Zhang, G. Lin, C. Lu, F. Gong, H. Xiao, G. Lu. 

P-28 
ANTIMULLERIAN HORMONE LEVELS FORECAST PATIENT PER­FORMANCE IN IVF CYCLES WHEN OBTAINED IMMEDIATELY PRIOR TO BEGINNING FSH STIMULATION. 
A. S. Blazar, G. Lambert-Messerlian, R. Hackett, Y. Dondik. 

P-29 
LUTEAL PHASE CIRCULATING VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF), ESTRADIOL (E2) AND PROGES­TERONE (P) LEVELS AFTER GNRH AGONIST TRIGGER. 
L. L. Engmann, J. J. Romak, J. C.Nulsen, D. B. Maier, J. J. Peluso, C. A. Benadiva. 

P-30 
DIFFERENCES OF THE FORMS OF HATCHING AND PREGNANCY RATES, BETWEEN LASER-ASSIST-ED ICSI AND NON-LASER ICSI. 
H. Miyata, N. Fukutomi, J. Matsuba, M. Yokota, A. Koizumi, T. Tomiyama. 

P-31 
DIAGNOSIS OF POLYCYSTIC OVARIAN SYNDROME (PCOS) OR ENDOMETRIOSIS IS ASSOCIATED WITH LOWER PREGNANCY RATES IN WOMEN UNDERGOING IN VITRO FERTILIZATION AND EMBRYO TRANSFER (IVF-ET). 
M. F. Mitwally, M. Imam, M. Fakih, M. Ashraf, M. P. Diamond, M. Abuzeid. 

P-32 
CONVERSION OF HIGH RESPONSE IUI PATIENTS TO IVF IS AN EFFECTIVE ALTERNATIVE TO CYCLE CANCELLATION. 
D. R. Kinzer, C. B. Barrett, R. D. Powers, M. M. Alper. 

P-33 
CONVENTIONAL IN VITRO FER­TILIZATION (IVF) IS AS EFFICIENT AS INTRACYTOPLASMIC SPERM INJECTION (ICSI) IN ART CYCLES WITH LOW NUMBER OF RETRIEVED OOCYTES AND NOR­MAL SPERM PARAMETERS. S.-H. Lee, H. Song, M. K. Kim, M. K. Koong, I. O. Song, J. H. Jun. 

P-34 
LIFE TABLE ANALYSIS OF DELIV­ERY AFTER IVF/ICSI SINCE THE INTRODUCTION OF SINGLE EMBRYO TRANSFER. 
D. De Neubourg, M. Elseviers, C. Daels, K. Mangelschots, E. Van Royen, M. Vercruyssen. 

P-35 
INCLUDING A LOW DOSE OF hCG ALONG WITH GNRH AGONIST "TRIGGER" REDUCES EARLY PREGNANCY LOSS RATES WHEN COMPARED TO THE AGONIST ALONE. 
B. S. Shapiro, S. T. Daneshmand, F. C. Garner, M. Aguirre, S. Thomas. 

P-36 WITHDRAWN 

P-37 
GONADOTROPIN RELEASING HORMONE AGONISTS VERSUS ANTAGONISTS IN WOMEN WITH POLYCYSTIC OVARY DISEASE UNDERGOING ICSI. 
K. Sofuoglu, B. Kars, E. Caliskan, D.Oztekin, N. Tug, T. Cetinkaya. 

P-38 
THE EFFECT OF CUMULUS CO­CULTURE IN ICSI. 
J. Matsuba, N. Fukutomi, H. Miyata, A. Koizumi, M. Yokota, T. Tomiyama. 

P-39 
THE COST EFFECTIVENESS AND HEALTH OUTCOMES OF IN VITRO FERTILIZATION (IVF) AS A MANDATED BENEFIT. 
K. R. Omurtag, T. L. Toth. 

P-40 
EVALUATION OF PREGNANCY OUTCOME AFTER ESTABLISH­MENT OF SINGLE BLASTOCYST TRANSFER (SET) CRITERIA IN IN VITRO FERTILIZATION AND EGG RECIPIENT (IVF/ER) EMBRYO TRANSFER (ET) CYCLES. 
D. C. Merryman, S. E. Stringfellow, C. Y. Gibbs, C. A. Long, V. L. Houserman, K. L. Honea. 

P-41 
METHODOLOGIC ISSUES AND STATISTICAL APPROACHES TO THE ANALYSIS OF MULTIPLE CYCLE DATA FROM COUPLES UNDERGOING IN VITRO FERTILIZATION (IVF). 
S. A. Missmer, K. R. Pearson, L. M. Ryan, J. D. Meeker, D. W. Cramer, R. Hauser. 

P-42 
ANTRAL FOLLICLE COUNT CAN BE UTILIZED IN THE PREDICTION OF OVARIAN RESPONSE AND THE PROFITABILITY OF THE OOCYTE DONATION PROGRAM, BUT CAN NOT PREDICT THE IVF OUTCOME. 
M. A. B. Melo, N. Garrido, J. Bellver, M. Meseguer, A. Pellicer, J. Remohi. 

P-43 
THE ROLE OF ESTROGEN SUP­PLEMENTATION IN ART CYCLES INVOLVING ASSISTED HATCHING. 
M. E. Abusief, A. M. Griffin, S. A. Missmer, E. S. Ginsburg, C. Racowsky. 

P-44 
PREGNANCY OUTCOME AFTER FROZEN/THAWED EMBRYO TREATMENT FOLLOWING CRYOPRESERVATION OF ALL EMBRYOS IN CYCLES WITH EXCESSIVE OVARIAN RESPONSE. 
G. R. Verwoerd, K. Marikinti, T. Mathews, M. C. Macnamee. 

P-45 
EFFICACY OF L-CARNITINE IN REVERSING THE ANTIPROLIFERATIVE EFFECTS OF TNF-a ON MOUSE EMBRYOS IN VITRO. 
H. Abdelrazik, A. Agarwal, G. Mansour, S. Gupta, E. Sabanegh, R. Sharma.

P-46 
ESTRADIOL LEVELS AFTER HUMAN CHORIONIC GONADOTROPIN (HCG) ADMINISTRATION ARE NOT PREDICTIVE OF IVF OUTCOME: ANALYSIS OF 7,474 INITIAL FRESH IVF CYCLES. 
J. Agard, D. Glujovsky, M. I. Shamonki, J. Fratarrelli, P. A. Bergh. 

P-47 
EFFECT OF BODY MASS INDEX (BMI) ON IN VITRO FERTILIZA­TION (IVF) OUTCOME IN YOUNG WOMEN. 
K. Martinuzzi, S. Ryan, M. Luna, A. B. Copperman.

P-48 
DAY-3 EMBRYO MORPHOLOGY AND PROGRESSION TO BLASTOCYST: AN ANALYSIS OF 34,708 EMBRYOS. 
C. M. Wambach, M. I. Shamonki, D. Glujovsky, K. A. Miller, P. A. Bergh. 

P-49 
A PROSPECTIVE, RANDOMIZED COMPARISON TRIAL OF OVARIAN FOLLICULAR RE-ASPIRATION AT OOCYTE RETRIEVAL AMONG PATIENTS WITH REDUCED OVAR­IAN RESPONSE UNDERGOING ART. 
E. D. Levens, M. D. Payson, F. W. Larsen. 

P-50 
GONADOTROPIN RELEASING HORMONE (GnRH) AGONIST TRIGGERS: DO SUBSEQUENT ESTRADIOL (E2) AND PROGESTERONE (P) LEVELS PREDICT PREGNANCY? 
E. B. Johnston-MacAnanny, C. A. Benadiva, L. J. Siano, J. C. Nulsen, D. B. Maier, L. L. Engmann. 

P-51 
LOW-DOSE ASPIRIN USE DOES NOT IMPROVE ART OUTCOMES IN POOR RESPONDERS. 
J. L. Frattarelli, G. D. E. McWilliams, 
M. J. Hill, K. A. Miller, R. T. Scott. 

P-52 
REPEATED IVF FAILURES FOL­LOWED BY SUCCESSFUL DONOR OOCYTE CYCLE. 
M. K. Martin-Johnston, A. N. Beltsos, M. L. Uhler, E. Grotjan. 

P-53 
OBSTETRIC OUTCOME ANALY­SES OF 132 CYCLES IN VITRO FERTILIZED PREGNANCIES COMPLICATED BY MODERATE AND SEVERE OVARIAN HYPERSTIMULATION SYNDROME. 
Y. H. Fan, J. Qiao, G. A. Chen, P. Liu, C. H. Ma, X. N. Chen.

P-54 
IMPLICATIONS OF AN INAPPRO­PRIATE RISE IN ESTRADIOL WITH INITIATION OF ANTAGONISTS. 
J. G. Scotchie, M. Will, M. A. Fritz, A. Z. Steiner. 

P-55 
A RETROSPECTIVE ANALYSIS OF PREGNANCY AND BIRTH OUT­COMES FROM IN VITRO FERTILIZATION COMPARED TO SPONTA­NEOUSLY CONCEIVED PREGNANCIES FROM A SINGLE INSTITUTION. 
J. Milosavajevic, E. Y. Strawn, P. Robb, M. Roesler, A. Granlund. 

P-56 
MOUSE IN VITRO FERTILIZATION AND CULTURE AND A SUBOPTI­MAL DIET ARE ASSOCIATED WITH DECREASED ANXIETY IN ADULT MALE OFFSPRING. 
P. F. Rinaudo, A. Donjacour, L. Delle Piane, F. Di Sebastiano, A. Dobson, G. Giritharan. 

P-57 
HUMAN OOCYTE OOLEMMA CHARACTERISTICS IS POSITIVELY RELATED TO EMBRYO DEVELOPMENTAL COMPETENCE AFTER ICSI PROCEDURE. 
M. A. Danfour, O. A. Elsraite, H. M. Asherkaci, M. S. Elmahaishi. 

P-58 
THE EFFECT OF SUBCLINICAL HYPERTHYROIDISM ON ICSI OUTCOME. 
E. Caliskan, K. Sofuoglu, B. Kars, D.C. Oztekin, N. Tug, T. Cetinkaya. 

P-59 
ANTI-MULLERIAN HORMONE (AMH) LEVELS IN YOUNG PATIENTS: A PREDICTOR FOR RESPONSE TO GONADOTROPIN STIMULATION? 
J. Q. Huang, S. Shastri, E. Barbieri, A. Bongiovanni, S. D. Spandorfer, Z. Rosenwaks. 

P-60 
OUTCOME OF ASSISTED REPRODUCTION TECHNOLOGY (ART) IN WOMEN 40 YEARS AND OLDER WHO DECIDE TO USE THEIR OWN GAMETES. 
T. Marisa, V. Alberto, M. Gomez Peña, M. Guidobono, C. Lombardi, E.Young. 

P-61 
LASER ASSISTED HATCHING AND ICSI OUTCOME. 
V. Thomas, Y. Stephen, J. Justy, S. Hema, V. Thankam. 

P-62 
ELEVATED DAY 3 FSH/LH RATIO 2 IS ASSOCIATED WITH HIGHER RATES OF CANCELLATION IN IN­VITRO FERTILIZATION (IVF) CYCLES. 
K. E. Liu, E. M. Greenblatt.

P-63 
BLASTOCYST FORMATION AND PREGNANCY OUTCOME IN FROZEN-THAWED HUMAN EMBRYOS FROM CONVENTION­AL IVF OR ICSI. 
N. Wang, J. Han, Z. Lu, S. Liu, J. Yan, H. Chen.

P-64 
THE NUMBER OF BLASTOMERES ON DAY-2 AND THE PROGRES­SION TO BLASTOCYST: AN ANALYSIS OF 34,883 EMBRYOS. 
C. M. Wambach, A. Gueye, M. I. Shamonki, D. Glujovsky, K. A. Miller, P. A. Bergh. 

P-65 
GONADOTROPIN RELEASING HORMONE (GnRH) AGONIST TRIGGER FOLLOWING ANTAGONIST PROTOCOLS IN ANONY­MOUS OOCYTE DONORS MINIMIZES OVARIAN HYPER­STIMULATION SYNDROME. 
S. C. Wilkinson, S. A. Walker, B. A. Hayes, B. W. Donesky, J. S. Bird, A. R. Anderson.

P-66 
NITRIC OXIDE EXTENDS THE 'OOCYTE TEMPORAL WINDOW FOR OPTIMAL FERTILIZATION'. 
P. T. Goud, A. P. Goud, M. P. Diamond, B. Gonik, H. M. Abu-Soud. 

P-67 
ZONA PELLUCIDA THICKNESS DOES NOT PREDICT PREGNANCY OUTCOMES IN PATIENTS LESS THAN 38 YEARS OF AGE UNDER­GOING IN VITRO FERTILIZATION: RESULTS FROM A PROSPECTIVE, RANDOMIZED TRIAL ON ASSISTED HATCHING. 
A. R. Hagemann, L. T. Lawrence, E. S. Jungheim, S. E. Lanzendorf, V. S. Ratts, R. R. Odem. 

P-68 
DOES LEUTINIZING HORMONE ACTIVITY IN THE FORM OF LOW­DOSE HCG OR HMG PRODUCE BETTER OUTCOMES FOR GNRH ANTAGONIST ART CYCLES STIMULATED WITH RFSH? 
J. L. Frattarelli, B. T. Miller, B. Kaplan, E. Widra, R. T. Scott. 

P-69 
COMPARISON OF PREGNANCY OUTCOMES IN ANONYMOUS SHARED VERSUS EXCLUSIVE DONOR OOCYTE IN VITRO FER­TILIZATION (IVF) CYCLES. 
C. M. Mullin, S. Talebian, D. Keegan, M. E. Fino, J. A. Grifo, F. Licciardi. 

P-70 
INCREASED SEMINAL VISCOSITY IS ASSOCIATED WITH LOWER IMPLANTATION AND PREGNANCY RATES AFTER IN VITRO FERTILIZATION EMBRYO TRANSFER. 
N. Esfandiari, H. Burjaq, M. Javed, L.Gotlieb, R. F. Casper. 

P-71 WITHDRAWN 

P-72 
THE IN-VITRO VIABILITY, STEROIDOGENIC, AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) SECRETORY CAPACITY OF HUMAN LUTEINIZED GRANULOSA CELLS AFTER GNRH AGONIST TRIGGER. 
L. L. Engmann, C. A. Benadiva, J. J. Romak, J. C. Nulsen, D. B. Maier, J. J. Peluso. 

P-73 
PREDICTIVE FACTORS OF ASSISTED REPRODUCTIVE TECHNOLOGY OUTCOME IN WOMEN OVER THE AGE OF 40. 
A. Fujimoto, T. Fujiwara, Y. Osuga, T. Yano, O. Tsutsumi, Y. Taketani. 

P-74 
APPLICATION OF HUMAN UMBILICAL CORD SERUM (hUS) IN IN VITRO MATURATION (IVM) MEDI­UM AND ESTABLISHMENT OF CLINICAL PREGNANCIES. 
Z. Zhiguo, C. Yunxia. 

P-75 
POINT MUTATIONS IN OOCYTE MITOCHONDRIAL DNA (mtDNA) AND THEIR RELATIONSHIP TO CHANGES IN MITOCHONDRIAL MEMBRANE POTENTIAL (DYm), MATERNAL AGE, INFERTILITY DIAGNOSIS AND IVF CYCLE OUTCOME. 
R. A. Forman, B. Acton, A. Jurisicova, R. F. Casper. 

P-76 
INDIVIDUALIZED ASSESSMENT OF OOCYTE CUMULUS CELL HEALTH AND OOCYTE QUALITY, FERTILIZATION, EMBRYO DEVEL­OPMENT AND IMPLANTATION. 
P. A. Hassun, M. Ribeiro, A. M. Rocha, G. D. Smith, E. Motta, P. Serafini. 

P-77 
UNEXPECTED GENDER BIAS FOUND IN IVF CYCLES FOR SEX SELECTION. 
T. Mukherjee, M. Luna, A. De Venuta, E. Flisser, A. B. Copperman, J. Barritt. 

P-78 
THE PERSONAL ECONOMICS OF IVF: IMPACT OF TIME HORIZON, NUMBER OF EMBRYOS TRANSFERRED, QUALITY OF LIFE, AND CHOICE OF OUTCOME ON COST­EFFECTIVENESS FROM THE COUPLE'S PERSPECTIVE. 
E. R. Myers, T. A. Poulos, A. P. Hagy. 

P-79 
ELECTIVE CRYOPRESERVATION OF ALL EMBRYOS AFTER GNRH AGONIST TRIGGER IS NOT JUSTI­FIED BECAUSE OF THE COMPA­RABLE SUCCESS RATES BETWEEN FRESH AND CRYOTHAWED EMBRYO TRANSFERS. 
R. LaMonica, L. J. Siano, J. C. Nulsen, D. B. Maier, C. A. Benadiva, L. L. Engmann. 

P-80 
THE EFFECT OF SMOKING ON ART CYCLE PARAMETERS. 
G. Sahin, E. N. Tavmergen Goker, A. Akdogan, R. Levi, E. Tavmergen. 

P-81 
SEMEN INFECTION AND ICSI OUTCOME. 
V. Thomas, Y. Stephen, J. Justy, S. Hema, V. Thankam. 

P-82 WITHDRAWN

P-83 
ASSOCIATION OF SPERM CHROMATIN STATUS WITH EARLY PREGNANCY LOSS AND HIGH ORDER PREGNANCIES AFTER ICSI. 
R. Mahfouz, A. Agarwal, R. Sharma, M. Elsahfei, A. Fathi, M. Amer. 

P-84 
IMPROVEMENT OF PREGNANCY RATES BY LOW-DOSE METFORMIN IN IVF REPEATERS WITHOUT POLYCYSTIC OVARY SYNDROME: ITS MECHANISM AND INDICATION. 
M. Jinno, K. Kondou, M. Jinno, A. Watanabe, S. Takahashi, C. Urakami. 

P-85 
DOES ENDOMETRIAL aVß3 VIT­RONECTIN (ß3) EXPRESSION IN ENDOMETRIOSIS (ENDO) PATIENTS PREDICT ENHANCED OUTCOMES AFTER PROLONGED GNRH AGONIST (GNRHa) THERA­PY PRIOR TO IN VITRO FERTILIZATION (IVF)? 
E. S. Surrey, A. K. Lietz, R. L. Gustofson, D. A. Minjarez, W. B. Schoolcraft. 

P-86 
BLASTOCYST FORMATION AFTER INTRACYTOPLASMIC MORPHOLOGICALLY SELECTED SPERM INJECTION (IMSI) ACCORDING TO THE MORPHOLOGICAL INTEGRITY OF HUMAN SPERM NUCLEI. 
N. H. Zech, M. Bach, T. Neyer, A. Stecher, M. Zintz, P. Vanderzwalmen. 

P-87 
RESCUE ICSI AFTER FERTILIZATION FAILURE IN IN VITRO FERTILIZATION. 
C. Ma, J. Qiao, P. Liu, G. Chen. 

P-88 
ANTITHYROID ANTIBODIES AND REPRODUCTIVE SUCCESS IN PATIENTS UNDERGOING IN VITRO FERTILIZATION. 
M. Erdem, G. Gunaydin, U.Korucuoglu, S. Gumuslu, A. Erdem, O. Karabacak.

P-89 
HUMAN FOLLICULAR FLUID­INDUCED ACROSOME REACTION PREDICTS SPERM FERTILIZING ABILITY IN VITRO. M.-Z. Huang, J.-Z. Wu, C.-Q. Chen, A. D. Dorfmann.

P-90 
CLINICAL PREDICTORS OF HUMAN BLASTOCYST FORMATION IN VITRO. 
M. R. Thomas, C. S. Sipe, A. E. Sparks, A. Dokras, G. L. Ryan, B. J. Van Voorhis. 

P-91 
MICROBIAL GROWTH FROM THE TIP OF THE EMBRYO TRANSFER CATHETER DO NOT INFLUENCE PREGNANCY AND IMPLANTATION RATES AFTER ICSI. 
L. G. L. Maldonado, E. F. Trombela, F. F. Pasqualotto, W. Busato, A. Iaconelli, Jr, E. Borges, Jr. 

P-92 
A RETROSPECTIVE COMPARISON OF MICRODOSE FOLLICULAR PHASE AND LUTEAL PHASE GONADOTROPIN RELEASING HORMONE AGONIST (GNRH-a) SUPPRESSION FOR IN VITRO FERTILIZATION IN PATIENTS 30 YEARS OLD AND YOUNGER. 
E. D. Levens, B. W. Whitcomb, J. D. Kort, D. Materia-Hoover, E. C. Feinberg, F. W. Larsen. 

P-93 
STATISTICAL ANALYSIS OF MOR­PHOLOGIC CHARACTERISTICS OF OOCYTES: WHICH FACTORS MIGHT EFFECT THESE FEATURES AND WHICH CHARACTERISTICS MIGHT PLAY IMPORTANT ROLES DURING FERTILIZATION? A PROSPECTIVE STUDY. 
R. G. Aktas, C. Gazi, N. Arat, K. Sofuoglu, T. Cetinkaya, N. Tug. 

P-94 
FOLLICULAR OXIDATIVE PREDOMINANCE AS A FUNCTION OF MATERNAL AGE AND ITS EFFECT ON IVF OUTCOME. 
S. Kar, L. Samanta, G. B. N. Chainy. 

P-95 
ARE PARASITES CAPABLE OF INVADING FOLLICULAR FLUID? 
Z. R. Hubayter, C. J. Alexander, K. Thrift, Y. Zhao, L. A. Kolp, J. A. Garcia. 

P-96 
THE EFFECT OF SUBCLINICAL HYPOTHYROIDISM ON ICSI OUTCOME. 
E. Caliskan, K. Sofuoglu, D. C.Oztekin, B. Kars, S. Cakir, N. Tug. 

P-97 
THE EFFECT OF LEIOMYOMAS SMALLER THAN 5CM IN DIAMETER ON THE ICSI OUTCOME. 
K. Sofuoglu, D. C. Oztekin, E. Caliskan, B. Kars, T. Cetinkaya, N. Tug. 

P-98 
CLINICAL RESPONSE OF SUCCESSFUL DONOR OOCYTE CYCLES. 
C. J. Bush, A. N. Beltsos, K. L. Sasada, M. K. Martin-Johnston, M. L. Uhler, J. Liebermann. 

P-99 
CHOICE OF MEDICATION FOR OOCYTE MATURATION FOR IN VITRO FERTILIZATION (IVF) GONADOTROPIN RELEASING HORMONE (GNRH) ANTAGONIST CYCLES: HUMAN CHORIONIC GONADOTROPIN (HCG) VERSUS LEUPROLIDE ACETATE (LA). 
E. B. Johnston-MacAnanny, A. J. DiLuigi, C. A. Benadiva, D. B. Maier, J. C. Nulsen, L. L. Engmann.

P-100 
DO INCREASED THYROID ANTI­BODIES HAVE ANY EFFECT ON FIRST ART CYCLES OF EUTHYROID WOMEN? 
A. Akdogan, E. N. Tavmergen Goker, G. Sahin, A. G. Ozgen, R. Levi, E. Tavmergen. 

P-101 
IMPACT OF THE PERIPHERIC GRANULAR AREA OF THE HUMAN OOCYTE ON EMBRYO QUALITY AFTER ICSI: A PROSPECTIVE STUDY. 
A. Cepeda, N. Prados, P. Vime, J. Garcia-Ortega, G. Calderon, M. Fernandez-Sanchez. 

P-102 
THE EFFECT OF DIFFERENT DEGRANULATIONAL TIME ON PREGNANCY OUTCOME. 
J. Hu, Q. Liu, B. Xu, Y. Wei, X. Ren, G. Zhu.

P-103 
PRONUCLEAR MORPHOLOGY AS A PREDICTOR FOR HUMAN EMBRYO TRANSFER SELECTION ON DAY 3 OF CULTURE: A PROSPECTIVE STUDY. 
P. Vime, N. Prados, M. Crespo, E. Canales, R. Garcia, M. Fernandez-Sanchez. 

P-104 
ZYGOTES WITH A Z3 PRONU­CLEAR MORPHOLOGY SCORE ARE ASSOCIATED WITH HIGH CLINICAL PREGNANCY AND IMPLANTATION RATES. 
R. P. Gada, D. L. Walker, K. M. Barud, T. M. Galanits, C. C. Coddington III, D. Morbeck.

P-105 
OOCYTE ACTIVATION WITH CAL­CIUM (CA)-IONOPHORE IN A GLOBOZOOSPERMIC PATIENT: SUCCESSFUL PREGNANCY AND CHILDBIRTH. 
A. Tejera, J. L. De Pablo, M. Mollá, L. Muriel, E. Muñoz, A. Pellicer. 

P-106 
DOES SERUM PROGESTERONE LEVELS ON THE DAY OF HUMAN CHORIONIC GONADOTROPHIN ADMINISTRATION AFFECT IVF RESULTS? 
P. Barriere, A.-S. Duclos, D. Masson, M.-L. Langlois, T. Freour, M. Jean. 

P-107 
IS THERE A SUPERIOR PROTOCOL FOR PATIENTS WITH POOR OVARIAN RESPONSE? A RETROSPECTIVE ANALYSIS OF 1,719 CYCLES. 
E. Maman, M. Baum, R. Machtinger, D. Seidman, J. Dor, A. Hourvitz. 

P-108 
HIGH BMI IS AN INDEPENDENT PREDICTOR OF UNSUCCESSFUL FRESH BLASTOCYST TRANSFER. 
A. Van Arsdale, M. Traub, S. Jindal, L. Pal, N. Santoro. 

P-109 
COMPARING MEASUREMENTS OF ENDOMETRIAL CAVITY LENGTH PERFORMED AT HYS­TEROSCOPY WITH TRANSVAGI­NAL AND PELVIC ULTRASOUND BEFORE IN-VITRO FERTILIZATION. 
D. S. Castellotti, A. S. Cambiaghi. 

P-110 
ARE WE JUSTIFIED IN TRANSFERRING MORE EMBRYOS IN OLDER WOMEN? 
T. N. Hickman, L. J. McKenzie, M. K.Clark, M. R. Brinker, D. P. O'Connor, W. B. Schoolcraft.

P-111 
MONOZYGOTIC TWINNING PRESENT IN ASSISTED REPRODUCTIVE TECHNIQUE: ANALYSIS OF 7 CASES. 
Z. Xiaohui, C. Yunxia. 

P-112 
DETERMINING THE PREDICTIVE VALUE OF DAY 3 EMBRYONIC MORPHOLOGY AND CELL STAGE ON ULTIMATE EMBRYO QUALITY. 
T. Turner, R. Fields, H. Werland, L. J. Hansard, T. C. Vaughn, K. M. Silverberg. 

P-113 
CORRELATION BETWEEN FOLLICULAR LH AND OOCYTE MATURITY AND FERTILIZATION. LOOKING FOR THE "LH WINDOW". 
E. Bosch, E. Bosch-Bastida, A. Rodriguez-Ineba, L. Dieguez, A. Romeu, L. Blasco. 

P-114 
IN VITRO FERTILIZATION CAN BE SUCCESSFULLY ACCOMPLISHED WITHOUT ROUTINE ESTRADIOL MONITORING: A RANDOMIZED PILOT STUDY. 
E. Y. Strawn, M. Roesler, A. Granlund, S. Bohling.

P-115 
OUTCOMES IN IN VITRO FERTILIZATION (IVF) CYCLES WHICH DISPLAY DYSYNCHRONOUS FOLLICULAR GROWTH. 
R. S. Murray, R. V. Simonsen, R. W. Ke, W. H. Kutteh. 

P-116 
INVERSE CORRELATION BETWEEN FEMALE PATIENT'S AGE AND EMBRYONIC CAVITATION RATE OF HUMAN EMBRYOS CULTURED IN VITRO. 
N. R. Stoddart, L. E. Phan, S. B.Kristiansen, S. D. Fleming. 

P-117 
LENGTH OF GESTATION AND BIRTH WEIGHT FOLLOWING IN VITRO FERTILIZATION IN PATIENTS WITH PRIOR FALLOPI­AN TUBE LIGATION. 
J. A. Attaman, E. Kennard, C. Friedman. 

P-118 
INTRACYTOPLASMIC SPERM INJECTION (ICSI) IS A BETTER CHOICE THAN CONVENTIONAL IN VITRO FERTILIZATION (IVF) IN ASSISTED REPRODUCTION CYCLES WITH ELEVATED SPERM DNA FRAGMENTATION. 
F. Bronet, A. Pacheco, C. Bou, D. Becerra, M. San Celestino, J. Garcia-Velasco. 

P-119 
THREE OR MORE PRIOR COH CYCLES: A POOR PROGNOSTIC PREDICTOR FOR 1ST IVF-ET CYCLE IN PATIENTS WITH UNEXPLAINED INFERTILITY (UI). 
M. A. Lederman, M. Chuang, S. K. Jindal, L. Pal, A. J. Polotsky, N. Santoro. 

P-120 
THE IMPACT OF THE DURATION OF ESTRADIOL SUPPLEMENTATION AND PEAK SERUM ESTRA­DIOL ON FROZEN BLASTOCYST­EMBRYO TRANSFER OUTCOME. 
B. J. Yauger, B. W. Whitcomb, E. D. Levens, S. Hennessy, F. W. Larsen. 

P-121 
SPERM PREPARATION TECHNIQUES AND THEIR EFFECT ON SEMEN QUALITY AND ICSI OUTCOME. 
M. E. Hammadeh, L. EL-Masri, P. Rosenbaum, W. Schmidt, C. Fischer-Hammadeh. 

P-122 
COMPARISON OF TWO SYSTEMS TO CULTURE HUMAN EMBRYOS UP TO DAY 3: A PROSPECTIVE RANDOMIZED STUDY. 
S. Verza, Jr., D. T. Schneider, S. C. Esteves. 

P-123 
CAN RECOMBINANT HUMAN CHORIONIC GONADOTROPIN (r-hCG) LOWER THE INCIDENCE OF OVARIAN HYPERSTIMULATION SYNDROME (OHSS) IN PCO? 
S. K. Goswami, S. Ghosh, R.Chattopadhyay, S. Sharma, B. N. Chakravarty. 

P-124 
ASSOCIATION OF BODY MASS INDEX WITH TREATMENT OUTCOMES ON ASSISTED REPRODUCTION TREATMENT IN KOREA. 
M. J. Yeon, C. W. Park, I. O. Song, M. K. Koong, I. S. Kang.

P-125 
ELECTIVE SINGLE BLASTOCYST TRANSFER IN A SELECTED GROUP OF PATIENTS DOES NOT ADVERSELY AFFECT THE PROBA­BILITY OF CONCEPTION AND REDUCES THE PROBABILITY OF TWIN GESTATION. 
L. L. Engmann, L. J. Siano, D. W. Schmidt, C. A. Benadiva, D. B. Maier, J. C. Nulsen.

P-126 
LIVE BIRTH RESULTS IN OPTIMAL AND SUBOPTIMAL EMBRYO QUALITY TRANSFERS IN NATIVE AND DONOR EGGS CYCLES. 
M. Ruiz, J. Garcia, P. Vime, M. Crespo, N. Prados, M. Fernandez-Sanchez. 

P-127 
MONOCHORIONIC-TRIAMNIOTIC TRIPLET PREGNANCY AFTER IN VITRO FERTILIZATION, EMBRYOS CRYOPRESERVATION, ASSISTED HATCHING, AND THREE-EMBRYO TRANSFER. 
J. P. Ou, G. L. Zhuang, C. Q. Zhou, M. F. Zhang.

P-128 
ENHANCED DIAGNOSTIC TESTING OF SPERM MATURATION IN INTRACYTOPLASMIC SPERM INJECTION CASES WITH ANILINE BLUE EOSIN (ABE) ASSAY. 
S. S. Chuan, A. D. Wong, W. C. Patton, J. D. Jacobson, J. U. Corselli, P. J. Chan.

P-129 
LUTEAL ESTRADIOL PROTOCOL PRECEEDING STIMULATION IN GNRH ANTAGONIST ICSI CYCLES: A COMPARISON TO NON PREVIOUSLY TREATED CYCLES. 
M. d. C. B. Souza, C. A. Rocha, A. C. A. Mancebo, C. A. Henriques, H. C. N. Santos.

P-130 
SELECTION OF FIRST IN VITRO FERTILIZATION (IVF) CYCLE STIMULATION PROTOCOL FOR GOOD PROGNOSIS PATIENTS: GNRH ANTAGONIST VERSUS AGONIST PROTOCOLS. 
E. B. Johnston-MacAnanny, A. J. DiLuigi, L. L. Engmann, D. B. Maier, C. A. Benadiva, J. C. Nulsen. 

P-131 
WHAT IS A MORE EFFECTIVE PROTOCOL BETWEEN CONVENTIONAL IVF AND ICSI TO FERTILIZE OOCYTES WITH THE SPERM THAT SHOWS STRICT MORPHOLOGY SCORE (SMS) 4-14%? 
S. Kang, C. Ryu, J. Lee, Y. Seo, S. Roh, H. Chi. 

Back to the Top

P-132 
THE REPRODUCTIVE OUTCOME OF RESCUE ICSI CYCLES WITH A COMPLETE FERTILIZATION FAILURE AFTER IN VITRO FERTILIZATION INSEMINATION IS CONDITIONED BY THE NUMBER OF OOCYTES REINSEMINATED. 
R. C. Inza, C. Montanari, A. Valcarcel, M. Gomez Pena, E. Young, E. Lombardi. 

P-133 
FAILED FERTILISATION: A REVIEW OF APPROXIMATELY 6000 CASES OF IVF/ICSI. 
J. Taylor, B. Collins, G. Grudzinskas, A. H. Handyside, L. M. Shaw, A. R. Thornhill. 

P-134 
CAN THE FOLLICULAR MICROENVIRONMENT IDENTIFY LIKELIHOOD OF CYTOPLASMIC MATURATION AND SUBSEQUENT FERTILIZATION? 
J. D. Lamb, S. Shen, L. Jalalian, S. L.Benedict, M. P. Rosen, M. I. Cedars. 

P-135 
THE EFFECTIVE PREVENTION OF MULTIPLE PREGNANCIES BY ELECTIVE SINGLE EMBRYO TRANSFER. 
R. Komaba, M. Maeda, N. Sugawara, Y. Araki.

P-136 
THE EFFECT OF SPERM QUALITY (DNA INTEGRITY, DNA STRAND BREAKS) ON FERTILIZATION AND SPERM CHROMATIN CONFIGURATION OF FAIL FERTILIZED OOCYTES AFTER ICSI. 
M. E. Hammadeh, T. Dostert, P. Rosenbaum, W. Schmidt, C. Fischer-Hammadeh. 

P-137 
COMPARISON OF TWO ICSI TECHNIQUES USING SIBLING OOCYTES. 
M. Duke, M. Simpkins, A. B. Copperman, A. DeVenuta, L. Valluzzo, J. Barritt.

P-138 
MICROTUBULE ORGANIZATION DURING EGG CLEAVAGE WITHOUT SPERM CENTROSOME. 
Y. Terada, M. Tachibana, T. Ugajin, T. Murakami, N. Yaegashi, K. Okamura. 

P-139 
ASSESSMENT OF FOLLICULAR NUMBER IN CONTROLLED OVARIAN HYPERSTIMULATION (COH)/INTRAUTERINE INSEMINATION CYCLES (IUI) AS PREDICTORS OF SUCCESS. 
J. O. Doyle, K. Pearson, D. Kuleta, J.C. Petrozza.

P-140 
DOES ICSI COMPENSATE FERTILIZATION FAILURE OF CONVENTIONAL IVF IN SPLIT INSEMINATION CYCLES? M.-R. Shin, S.-B. Hong, D.-W. Park, S.-H. Lee, I. O. Song, J. H. Jun.

Back to the Top

IMPLANTATION 

P-141 
INTENTIONAL ALL BLASTOCYSTS VITRIFICATION PROGRAM COULD BE THE MOST USEFUL STRATEGY FOR WOMEN WITH MULTIPLE FAILURES OF CONCEPTION AFTER FRESH IVF/ICSI-ET. 
C. Oka, T. Mukaida, T. Goto, K. Takahashi. 

P-142 
ENDOMETRIAL GLYCODELIN-A EXPRESSION IN PATIENTS WITH IVF FAILURE. 
H. B. Zeyneloglu, A. Ilgin, N. Haberal, G. Onalan.

P-143 
MILK FAT GLOBULE-EGF-FACTOR 8 (MFG-E8), A PROTEIN LINKING APOPTOTIC CELLS TO PHAGO­CYTES, IS EXPRESSED IN HUMAN ENDOMETRIUM DURING THE WINDOW OF IMPLANTATION. 
A. Franchi, S. Bocca, J. H. Zaret, S.Oehninger. 

P-144 
MOCK EMBRYO TRANSFER PERFORMED AT THE TIME OF OOCYTE RETRIEVAL DOES NOT IMPAIR PREGNANCY RATE. 
H. J. Abu-Halimeh, F. Sanguineti, B. Rackow, P. Patrizio. 

P-145 
ENDOCRINE EFFECTS ON ENDOMETRIUM IN HUMAN ECTOPIC GESTATION. 
R. F. Savaris, A. C. Hamilton, B. A. Lessey, L. C. Giudice. 

P-146 
ONLY SUCCESSFULLY IMPLANTED HUMAN BLASTOCYTS ARE ABLE TO DOWNREGULATE THE MATERNAL IMMUNRESPONSE IN VITRO. 
J. M. de los Santos, V. Serra, B. Gadea, A. Pellicer, J. Remohi, M. J. de los Santos Molina. 

P-147 
VEGF RECEPTOR-2 (VEGFR-2) AND VEGFR-3 MEDIATE PERI-IMPLANTATION UTERINE ANGIOGENESIS DURING EARLY PREGNANCY DEVELOPMENT. 
N. C. Douglas, H. Tang, R. Gomez, B. Pytowski, M. V. Sauer, R. C. Zimmermann. 

P-148 
ß3 INTEGRIN AND ITS LIGAND OSTEOPONTIN ARE COEXPRESSED IN HUMAN ENDOMETRIAL EPITHELIAL AND STROMAL CELLS DURING THE MENSTRUAL CYCLE. 
X. Liu, J. Wang, G. Zhu, G. Zhong. 

P-149 
ALTERATION OF MATERNAL MEIS1 EXPRESSION BY IN VIVO GENE TRANSFECTION AFFECTS IMPLANTATION. 
B. Xu, G. Zhu.

P-150 
THE USE OF LOW-DOSE ASPIRIN AND PREDNISONE DOES NOT IMPROVE THE PREGNANCY RATES IN PATIENTS UNDERGOING IN VITRO FERTILIZATION OR INTRACYTOPLASMIC SPERM INJECTION IN ANTAGONIST CYCLE REGIMEN. 
F. P. Ferreira, R. Fraietta, J. Haddad Filho, A. P. Cedenho. 

P-151 
VERY EARLY HCG DYNAMICS PREDICT PREGNANCY LOSS AT UP TO 10 WEEKS GESTATION. 
S. T. Daneshmand, B. S. Shapiro, F. C. Garner, M. Aguirre, S. Thomas, A. Udoh. 

P-152 WITHDRAWN 

P-153 
EFFECT OF PIROXICAM TREATMENT ON PREGNANCY RATE IN INTRACYTOPLASMIC SPERM INJECTION (ICSI). 
M. Asgharnia, M. Mehrafza, M. Oudi, A. Hoseeieni.

P-154 
VAGINAL SILDENAFIL SELECTIVELY IMPROVES UTERINE RECEPTIVITY IN WOMEN WITH POORLY ESTROGENIZED ENDOMETRIUM. 
G. Sher, J. Fisch, L. Keskintepe. 

P-155 
IS FACTOR V LEIDEN MUTATION A CAUSE OF IMPLANTATION FAILURE? 
B. Rudick, I. Su, M. Sammel, G.Kovalevsky, A. Shaunick, K. Barnhart. 

P-156 
DOES SPERM MORPHOLOGY AFFECT THE OUTCOME OF ICSI (INTRACYTOPLASMIC SPERM INJECTION) CYCLES? 
M. I. Riqueros, M. Florensa, M. Esbert, A. Calderon, A. Ballesteros, G. Calderon. 

P-157 
ROLE OF ARGINASE IN BEWO CELLS, A HUMAN TROPHOBLAS­TIC CELL. 
T. Ishikawa, T. Harada, Y. Shimizu, T. Kubota. 

P-158 
ASSESSMENT OF IMPLANTATION WINDOW BY POWER DOPPLER VELOCIMETRY IN FROZEN EMBRYO TRANSFER. 
S. Ghosh, R. Chattopadhyay, S. K. Goswami, S. Sharma, T. Chacko, B. N. Chakravarty. 

P-159 
HIGHER ONGOING PREGNANCY RATES IN BLASTOCYST TRANSFER OF FROZEN-THAWED EMBRYOS IN NATURAL CYCLES THAN IN HORMONE REPLACE­MENT THERAPY CYCLES. 
P. Alama, M. A. B. Melo, G. Garcia, N. Garrido, M. Meseguer, J. Remohi. 

P-160 
THE CLINICAL APPLICATION OF COLOR DOPPLER ENERGY IN PREDICTING PREGNANCY OUTCOME DURING FROZEN THAWED EMBRYOS TRANSFER CYCLES. 
L. Wang, J. Qiao, R. Li, X. Zhen. 

P-161 
THE EFFECT OF MIFEPRISTONE ON CYTOKINES AND GROWTH FACTORS EXPRESSED BY THE DECIDUAL STROMAL CELLS. 
S. Chen, G. Zhang, H. Song, L. Sun.

P-162 
COMPARISON OF IMPLANTATION RATE BETWEEN GnRH AGONIST AND ANTAGONIST CYCLES ACCORDING TO E2 LEVEL. 
C. W. Park, K. M. Yang, J. Y. Kim, M. K. Koong, I. S. Kang, I. O. Song.

P-163 
THE ROLE OF ENDOMETRIAL FUNCTION TEST (EFT ®) IN RECURRENT IMPLANTATION FAILURE (RIF) IN IVF. 
E. B. Johnston-MacAnanny, H. J. Kliman, D. B. Maier, J. C. Nulsen, C. A. Benadiva.

Back to the Top

LUTEAL PHASE SUPPORT 

P-164 
THE IMPACT OF LUTEAL PHASE SUPPORT ON PREGNANCY RATES IN INTRAUTERINE INSEMINATION CYCLES; A PROSPECTIVE RANDOMISED STUDY. 
S. Atmaca, M. Erdem, A. Erdem, I. Guler. 

P-165 
GNRH AGONIST ADMINISTRATION IN THE LUTEAL PHASE DOES NOT INCREASE CLINICAL PREGNANCY OR IMPLANTATION RATES FOLLOWING ICSI-ET IN GNRH AGONIST OR ANTAGONIST TREATED OVARIAN STIMULA­TION CYCLES. 
B. Ata, K. Yakin, B. Balaban, B. Urman. 

P-166 
LUTEAL PHASE SUPPORT IN IVF PATIENTS AT LOW RISK FOR OHSS: PROGESTERONE VS PROG­ESTERONE PLUS HCG. A PROSPECTIVE RANDOMIZED STUDY. 
C. Caligara, F. Carranza, J. Ramos, I. Rodríguez, A. González, M. Fernández-Sánchez. 

P-167 
LETROZOLE ADMINISTRATION DURING THE LUTEAL PHASE AFTER OVARIAN STIMULATION DRAMATICALLY REDUCES ESTRADIOL PRODUCTION: A RANDOMIZED, PLACEBO CON­TROLLED TRIAL. 
G. Quea, M. Piro, M. Mayoral, M.Ruiz, M. Toribio, J. A. Garcia-Velasco. 

P-168 
DOES LUTEAL ESTRADIOL SUPPLEMENTATION HAVE A ROLE IN LONG AGONIST CYCLES? 
E. A. Elgindy, D. O. Elhaig. 

P-169 
COMPARISON OF THE EFFICACY AND TOLERABILITY OF TWO FORMULATIONS OF VAGINAL PROGESTERONE FOR LUTEAL PHASE SUPPORT IN FROZEN EMBRYO TRANSFER CYCLES. 
V. T. N. Lan, P. Tuan, L. Canh, H. Tuong, C. M. Howles. 

P-170 
MOLECULAR AND CELLULAR MECHANISMS UNDERLYING OVARIAN HYPERSTIMULATION SYNDROME (OHSS): THE ROLE OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE. 
L. C. Ajonuma, L. L. Tsang, Y. W. Chung, C. H. Y. Wong, L. S. Ho, H. C. Chan. 

P-171 
LUTEAL PHASE SERUM FOLLICLE STIMULATING HORMONE AND ESTRADIOL LEVELS: EARLY PREDICTIVE MARKERS OF PREGNANCY OUTCOME. 
B. N. Chakravarty, S. Ghosh, S. K. Goswami, A. L. Ganesh. 

P-172 WITHDRAWN 

Back to the Top

OVARIAN FUNCTION 

P-173 
SERUM CA-125 AND PROGESTERONE LEVELS AS EARLY INDICATORS OF PREGNANCY VIABILITY ACHIEVED AFTER ART CYCLES, REVISITED. 
G. R. Van Thillo, R. C. Inza, V. A. Basconi, E. Young, G. L. Marconi, E. T. Young. 

P-174 
THE EXPRESSION OF MICRORNA (MIRNA), MIR-17, MIR-211 AND MIR-542 AND THEIR TARGET GENES, STAR, IL-1B AND COX2 IN FOLLICULAR CELLS DERIVED FROM WOMEN UNDERGOING ART. 
T. Toloubeydokhti, C. Alford, Y. Al-Katanani, X. Luo, R. S. Williams, C. Nasser. 

P-175 
MICROARRAY ANALYSIS OF GENE EXPRESSION IN THE PRIMATE OVULATORY FOLLICLE: SELECTED GENE TRANSCRIPTS INVOLVED IN CUMULUS­OOCYTE EXPANSION. 
F. Xu, J. D. Hennebold, J. Mueller, B. Lindenthal, M. A. Sackett, R. L. Stouffer. 

P-176 
SUTURE OF OVARY AFTER LAPAROSCOPIC EXCISION OF OVARIAN CYSTS PRESERVES MORE OVARIAN FUNCTION THAN BIPOLAR ELECTROCOAGULATION. C.-L. Hsieh, M.-Y. Chang, C.-S. Shiau, T.-T. Hsieh. 

P-177 
THE EXPRESSION OF MICRORNA (MIRNA) MIR-23A AND 23B AND THEIR TARGET GENE, CYP19A1 (AROMATASE) IN FOLLICULAR CELLS OBTAINED FROM WOMEN UNDERGOING ART. 
C. Alford, T. Toloubeydokhti, Y. Al-Katanani, K. C. Drury, R. Williams, N. Chenini.

P-178 
FOLLICULAR FLUID BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) LEVELS IN WOMEN UNDERGOING ART FOR DIFFER­ENT ETIOLOGIES OF INFERTILI­TY. 
E. Buyuk, D. B. Seifer. 

P-179 
GENE EXPRESSION PROFILING OF HUMAN PREANTRAL FOLLICLES. 
S. Rice, K. Laing, R. Finch, H. D.Mason. 

P-180 
FORKHEAD L2 (FOXL2), A GENE ASSOCIATED WITH PREMATURE OVARIAN FAILURE IS LIKELY REGULATED THROUGH PHOSPHORYLATION. 
M. D. Pisarska, F. Kuo, S. Tang, S. Khan. 

P-181 
OVARIAN AGING: WHAT DO OOCYTE MEMBRANE CHARACTERISTICS TELL US? 
S. Shen, M. P. Rosen, X. Yang, T. Choi, M. J. Abeyta, M. I. Cedars. 

P-182 
INFLUENCE OF FOLLICULAR GROWTH DYNAMICS ON PREGNANCY RATES IN CONTROLLED OVARIAN STIMULATION CYCLES. 
E. G. Lo Turco, R. P. Bertolla, J. Stevanato, A. B. Victorino, A. P. Cedenho. 

P-183 
HUMAN OVARIAN BIOPSIES AS A VIABLE SOURCE OF PREANTRAL FOLLICLES. 
S. Rice, K. Ojha, H. D. Mason.

Back to the Top

FEMALE REPRODUCTIVE ENDOCRINOLOGY 

P-184 
EXPRESSION OF CATHEPSIN B AND EPIDERMAL GROWTH FACTOR IN EUTOPIC AND ECTOPIC ENDOMETRIAL TISSUES OF PATIENTS WITH ENDOMETRIOSIS. 
Y.-H. Koo, C.-H. Kim, J.-S. Kim, S.-H. Kim, H. Chae, B.-M. Kang. 

P-185 
SERIAL MEASUREMENT OF SERUM ANTI-MULLERIAN HORMONE IN WOMEN UNDERGOING LAPAROSCOPIC CONSERVATIVE OVARIAN SURGERY. 
S. H. Han, B. C. Jee, C. S. Suh, K. C.Kim, W. D. Lee, S. H. Kim. 

P-186 
HUMAN CHORIONIC GONADOTROPIN EXHIBITS A DIRECT DOWN REGULATORY EFFECT ON THE EXPRESSION OF THE INHIBITORY TYPE II INTERLEUKIN 1 RECEPTOR IN HUMAN ENDOMETRIAL CELLS. 
A. Akoum, C. V. Rao, C. Herrmann-Lavoie. 

P-187
DECLINE IN PREGNANCY RATE (PR) WITH INSEMINATION OF HIGH MOTILE SPERM NUMBERS FOR INTRAUTERINE INSEMINATION (IUI).
H. Ansera, N. Virji, S. Nita, H. Julia, S. Linda, G. San Roman.

P-188
PREDICTIVE FACTORS OF OVARIAN RESPONSE IN GONADOTROPIN RELEASING HORMONE (GnRH) ANTAGONIST CYCLES.
M. Ganidou, E. M. Kolibianakis, C. A. Venetis, E. G. Papanikolaou, J. Bontis, B. C. Tarlatzis.

P-189
DIFFERENCES IN COLLAGEN EXPRESSION IN CUMULUS CELLS INDUCED BY LH-ACTIVITY OF HIGHLY PURIFIED MENOTROPHIN IN COMPARISON TO RECOMBINANT FSH IN A FOLLICLE CULTURE MODEL.
T. Adriaenssens, I. Segers, C. Mazoyer, S. Wathlet, J.-C. Arce, J. Smitz.

P-190
AGE-SPECIFIC CUT-OFFS FOR FSH ASSESSMENT OF OVARIAN FUNCTION: IMPROVED DIAGNOSIS OF PREMATURE OVARIAN AGING (POA).
D. Barad, A. Weghofer, N. Gleicher.

P-191
A NOVEL METHOD TO DETECT DYSFUNCTION OF STRESS RESPONSE-MECHANISM IN WOMEN WITH OVARIAN DYSFUNCTION: IMPLICATIONS OF CIRCADIAN RHYTHM IN SALIVARY CORTISOL FOR DIAGNOSIS AND TREATMENT.
M. Jinno, M. Jinno, A. Watanabe, S. Takahashi, C. Urakami.

P-192
DOWN-REGULATION OF HLA-G BOOSTED NK CELL-MEDIATED CYTOLYSIS IN JEG-3 CELLS CULTURED IN VITRO.
Y. Han, L. L. Sun, W. S. B. Yeung, J. H. Chen, Y. Q. Yao.

P-193
NORMAL ANTI-MULLERIAN HORMONE (AMH) LEVELS IN YOUNG SMOKING WOMEN UNDERGOING IVF HAVE NO PREDICTIVE VALUE FOR OVARIAN RESPONSE, INVERSELY TO NON SMOKERS. 
P. Barriere, T. Freour, D. Masson, S. Mirallie, M. Jean.

P-194
PRE-OVULATORY VERSUS OVULATORY INTRAUTERINE INSEMINATION IN CONTROLLED OVARIAN HYPERSTIMULATION CYCLES.
A. M. Propst, J. J. Thoppil, J. M. Groll, J. L. Frattarelli, R. D. Robinson, M. G. Retzloff.

P-195
RETINOID PATHWAY MEMBERS FUNCTION IN HUMAN OOCYTE MATURATION.
T. Bolbot, R. Sneeringer, Y. Monisova, S. W. Yoo, A. Penzias, A. Usheva-Simidjiyska.

P-196
ANGIOTENSIN-(1-7) AND ITS RECEPTOR MAS ARE EXPRESSED IN HUMAN ENDOMETRIUM DURING THE MENSTRUAL CYCLE.
J. Vaz-Silva, M. M. Carneiro, M. C. Ferreira, A. M. Reis, C. A. Witz, F. M. Reis.

P-197
TRIGGERING FINAL OOCYTE MATURATION WITH A GNRH AGONIST DOES NOT AFFECT APOPTOSIS OF FOLLICULAR GRANULOSA-LUTEIN CELLS. 
A. Palumbo, E. Acosta, O. Peña, V. Peña, J. Avila.

P-198
SERUM ANTI-MÜLLERIAN HORMONE (AMH) MEASUREMENT: INTERASSAY AGREEMENT AND TEMPERATURE STABILITY.
J. Zhao, S. Y. Ng, B. Rivnay, B. S. Leader.

P-199
EFFECTS OF KETOCONAZOLE ON OVARIAN RESPONSE IN PATIENTS WITH RESISTANT POLYCYSTIC OVARIAN SYNDROME UNDERGOING OVULATION INDUCTION.
M. Sadeghi, B. Hossein Rashidi, E. Sahrokh Tehraninejad, N. Memarpour.

P-200
ASSESSMENT OF DAY-3 FOLLICLE STIMULATING HORMONE (FSH) LEVELS ON THE BECKMAN COULTER ACCESS2 FOR OVARIAN RESERVE ASSESSMENT IMPROVES IN VITRO FERTILIZATION OUTCOME.
B. Combs, C. A. Jacobs, A. L. Davis, T. H. Taylor, Z. P. Nagy, R. J. Straub.

P-201
THE RELATIONSHIPS BETWEEN AGE, BMI, SERUM TESTOSTERONE AND INSULIN RESISTANCE WITH CARDIOVASCULAR DISEASE (CVD) RISK FACTORS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME (PCOS).
M. H. Dahan, F. Abbasi, G. Reaven.

P-202
A FORMAL TRANSITION PROGRAM FOR YOUNG ADULTS WITH REPRODUCTIVE ENDOCRINE DISORDERS.
K. Lynch, K. Rubin.

P-203
ISOFLAVONES REGULATE SECRETION OF LEUKEMIA INHIBITORY FACTOR AND TRANSFORMING GROWTH FACTOR AND EXPRESSION OF GLYCODELIN IN HUMAN ENDOMETRIAL EPITHELIAL CELLS.
J.-W. Xu, N. Yasui, K. Ikeda, W.-J. Pan, J. Watanabe, A. Yanaihara.

P-204
PREVALENCE OF INSULIN RESISTANCE IN A LATINOAMERICAN POPULATION OF INFERTILE NON PCOS WOMEN. A PROSPECTIVE CLINICAL TRIAL.
L. A. Sanchez, V. Siero, M. Perez.

P-205
LOCALIZATION OF ANGIOTENSIN-(1-7) AND ITS RECEPTOR MAS IN THE HUMAN OVARY.
D. R. P. Bouissou, R. A. Santos, A. F. Camargos, S. V. Pinheiro, A. M. Reis, F. M. Reis.

P-206
PREDICTORS OF A SPONTANEOUS LUTEINIZING HORMONE SURGE IN CONTROLLED OVARIAN HYPERSTIMULATION CYCLES.
K. Sproul, A. Huang, M. Landay, B. Trivax, J. Wu, A. DeCherney.

P-208
PREDICTION OF OUTCOME FOR WOMEN WITH SYMPTOMATIC FIRST TRIMESTER PREGNANCY: THE FOCUS SHOULD BE ON INTRAUTERINE RATHER THAN ECTOPIC GESTATION.
B. F. Casanova, M. D. Sammel, J. Chittams, K. Timbers, K. Barnhart.

P-209
IMPACT OF CONTINUING METFORMIN TREATMENT DURING PREGNANCY IN POLYCYSTIC OVARY SYNDROME (PCOS) PATIENTS.
C. Ruhlmann, G. Galante, G. Terrado, D. C. Gnocchi, L. Tessari, A. G. Martinez.

P-210 WITHDRAWN

Back to the Top

POLYCYSTIC OVARY SYNDROME 

P-211 
TRADITIONAL CARDIOVASCU­LAR (CV) RISK FACTORS FAIL TO PREDICT THE INCREASED PREVA­LENCE OF SUBCLINICAL CORONARY ARTERY DISEASE (CAD) IN YOUNG WOMEN WITH PCOS. 
R. R. Shroff, A. Kirschner, M. Maifeld, E. J. R. Van Beek, D. Jagasia, A. Dokras. 

P-212 
A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM IN THE VEGF GENE FOR POLYCYSTIC OVARY SYNDROME (PCOS). 
S. Song, E.-J. Lee, B. Oh, K. Kim, K.-H. Baek. 

P-213 
EFFECT OF WEIGHT AND INSULIN-SENSITIZATION AGENTS ON POLYCYSTIC OVARIAN SYN­DROME (PCOS)-ASSOCIATED INFERTILITY. 
X. L. Smith, R. W. Ke, A. M. Page, W. H. Kutteh.

P-214 
POLYCYSTIC OVARY SYNDROME IS ASSOCIATED WITH ELEVATED SERUM SOLUBLE CD40 LIGAND, A MARKER OF CORONARY ARTERY DISEASE. 
M. Oktem, E. E. Ozcimen, A. Uckuyu, I. Esinler, N. Bayraktar, H. B. Zeyneloglu. 

P-215 
ASSOCIATION OF THE ANDROGEN RECEPTOR GENE CAG REPEAT LENGTH POLYMORPHISM WITH THE RISK OF POLYCYSTIC OVARY SYNDROME (PCOS) IN KOREAN WOMEN. 
J. J. Kim, S. H. Yoon, K. R. Whang, S. H. Kim, Y. M. Choi, S. Y. Moon. 

P-216 
FOLLICULAR FLUID OF SINGLE FOLLICLES FROM WOMEN WITH PCOS CONTAINS HIGHER LEVELS OF MÜLLERIAN INHIBITING SUBSTANCE. 
L. T. Ku, S. T. Nakajima, M. E. McClure, Y. Siow. 

P-217 
CAN PREGNANCY RATE BE IMPROVED BY ADDITION OF GNRH ANTAGONIST TO GONADOTROPIN STIMULATED CYCLES IN WOMEN WITH POLYCYSTIC OVARY SYNDROME UNDERGOING OVULATION INDUCTION? A PROSPECTIVE RANDOMIZED STUDY. 
L. Stadtmauer, S. Zhao, S. Bocca, B. Pultz, S. Oehninger. 

P-218 
IDENTIFICATION OF OVER­EXPRESSED PROTEINS BY PROTEOMIC ANALYSIS USING HUMAN FOLLICULAR FLUIDS DERIVED FROM POLYCYSTIC OVARY SYNDROME (PCOS) PATIENTS. B.-C. Choi, Y.-S. Kim, M.-S. Kim, M.-K. Chung, C.-H. Choi, K.-H. Baek. 

P-219 
A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL COMPARING CHROMIUM PICOLINATE TO METFORMIN FOR THE TREATMENT OF INSULIN RESISTANCE IN OBESE, HISPANIC WOMEN WITH POLYCYSTIC OVARIAN SYNDROME. 
R. H. Fogle, M. B. Baker, S. K. Patel, L. M. Korst, F. Z. Stanczyk, R. Z. Sokol. 

P-220 
A RANDOMISED COMPARISON OF GANIRELIX AND CETRORELIX USE IN ICSI CYCLE OF WOMEN WITH POLYCYSTIC OVARY SYNDROME. 
B. Kars, K. Sofuoglu, E. Caliskan, D.C. Oztekin, G. Akdas, N. Tug. 

P-221 
COMPARING THE EFFICACY OF PRETREATMENT WITH METFORMIN AND DIANE-35 IN POLYCYSTIC OVARY SYNDROME. 
W. Liu, G. Lu, X. Li, J. Yang, X. Yang. 

P-222 
ANALYSIS OF CLINICAL DATA IN A LARGE-SCALE CHINESE WOMEN WITH POLYCYSTIC OVARY SYNDROME (PCOS). 
Y.-H. Shi, Z.-J. Chen, L. You, Y.-R. Zhao. 

P-223 
SERUM ADVANCED GLYCATION END-PRODUCTS IN SAUDI WOMEN WITH POLYCYSTIC OVARY SYNDROME: A PROSPECTIVE STUDY. 
A. A. Rouzi, M. M. Ardawi. 

P-224 
INSULIN RESISTANCE AND DYSLIPIDEMIA IN WOMEN WITH POLYCYSTIC OVARY SYNDROME (PCOS), A CASE CONTROL STUDY. 
O. Valkenburg, R. P. M. Steegers-Theunissen, H. P. M. Smedts, B. C. J. M. Fauser, T. E. Westerveld, J. S. E. Laven. 

P-225 
METFORMIN IN FIRST-LINE TREATMENT IN STERIL POLYCYSTIC OVARY SYNDROME PATIENTS WITH NEITHER OBESITY NON INSULIN RESISTANCE. 
M. Attie, E. Lombardi, L. Sicaro, E. Young. 

P-226 
ABNORMAL PROTEIN EXPRESSION PROFILES IN HUMAN OVARIES FROM POLYCYSTIC OVARY SYNDROME PATIENTS. 
M. Jin, J. Cai, X. E. Lu, Q. Luo, H. F. Huang. 

P-227 
GENE EXPRESSION OF IGF-1 RECEPTOR IN HUMAN LUTEINIZED GRANULOSA CUMULUS CELLS FROM NON OBESE AND NON INSULIN RESISTANT WOMEN WITH POLYCYSTIC OVARY SYNDROME (PCOS) WITH AND WITHOUT METFORMIN TREATMENT. 
L. F. Santana, J. M. Fernández­Santoss, M. J. Hernáez, C. Caligara, R. M. Reis, M. Fernández-Sánchez.

P-228 
MICROCIRCULATORY POST­OCCLUSIVE CAPILLARY RECRUITMENT IS IMPAIRED IN WOMEN WITH POLYCYSTIC OVARY SYNDROME. 
I. J. G. Ketel, E. H. Serne, P. G. A. Hompes, Y. M. Smulders, C. D. A. Stehouwer, C. B. Lambalk. 

P-229 
THE ROLE OF TUMOR NECROSIS FACTOR-RELATED APOPTOSIS­INDUCING LIGAND, DEATH RECEPTOR 4 AND DECOY RECEPTOR 1 DURING FOLLICLE DEVELOPMENT IN POLYCYSTIC OVARY SYNDROME RATS. 
J. Zhang, G. Zhu, X. Wang, L. Hu, B. Xu. 

P-230 
PREGNANCY OUTCOME AFTER IVF IN POLYCYSTIC OVARY SYNDROME, ENDOMETRIOSIS, TUBAL FACTOR-ASSOCIATED AND ICSI IN MALE FACTOR INFERTILITY. 
X. Liang, H. Zeng, X. Yang, J. Du, Y. Li, G. Zhuang. 

P-231 
IVF OUTCOMES IN PATIENTS WITH PCOS DOWN-REGULATED WITH GNRH-ANTAGONISTS. 
L. Detti, W. Khoder, D. R. Ambler, F. D. Yelian, M. P. Diamond, E. E. Puscheck. 

P-232 
PREGNANCY OUTCOME AFTER THE USE OF METFORMIN IN PCOS PATIENTS. 
M. A. Bedaiwy, O. M. Shabaan, E. Ryan, R. F. Casper. 

P-233 
CORRELATION OF ADRENAL ANDROGEN OUTPUT AND GLUCOCORTICOID OUTPUT WITH CLINICAL, ENDOCRINE AND METABOLIC PARAMETERS OF PCOS. 
M. I. Mohamed, A. J. Duleba. 

P-234 
INFLAMMATORY MARKERS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME. 
M. M. Ardawi, A. A. Rouzi. 

P-235 
A MULTIDISCIPLINARY POLYCYSTIC OVARIAN SYNDROME (PCOS) CLINIC: A NEW MODEL FOR CARE AND RESEARCH. 
J. D. Lamb, W. B. Closshey, H. G. Huddleston, G. Davis, L. T. Zane, M. I. Cedars.

P-236 
ASSOCIATION BETWEEN THE SINGLE NUCLEOTIDE POLYMOR­PHISM OF THE SORBIN AND SH3-DOMAIN-CONTAINIG-1 (SORBS1) GENE AND POLYCYSTIC OVARY SYNDROME (PCOS) IN A KOREAN POPULATION. S.-W. Choi, J.-M. Park, E.-J. Lee, B.-H. Gu, K.-H. Baek.

P-237 
ENHANCED LEVELS OF F11R RECEPTOR (F11R/JAM-1/JAM-A) IN PCOS PATIENTS. 
O. Muneyyirci-Delale, A. Babinska, V. L. Nacharaju, M. Dalloul, E. Kornecki.

Back to the Top

OBESITY AND METABOLISM 

P-238 
NORMALIZATION OF REPRODUCTIVE HORMONES, INSULIN RESISTANCE AND ADIPOKINES AFTER BARIATRIC SURGERY OCCURS IN THE ABSENCE OF A RISE IN REVERSE T3. 
A. J. Polotsky, D. Rochester, A. Jain, G. Zeitlian, K. Gibbs, N. Santoro.

P-239 
ARE IVF PATIENTS WITH AN INCREASED BODY MASS INDEX LESS LIKELY TO HAVE GOOD QUALITY EMBRYOS? 
D. M. Davies, A. Finn, I. Hardy, J. A. Hill. 

P-240 
THE RELATIONSHIP OF BARIATRIC SURGERY TO MUL­LERIAN INHIBITING SUBSTANCE. 
Z. O. Merhi, H. Minkoff, J. Feldman, J. Macura, D. B. Seifer. 

P-241 
OVERWEIGHT AND OBESE INFERTILE WOMEN LACK ADEQUATE KNOWLEDGE OF THE EFFECTS OF OBESITY ON REPRODUCTIVE HEALTH. 
M. R. Thomas, B. J. Van Voorhis, J. Blaine, A. Dokras. 

P-242 
CORRELATION OF BODY MASS INDEX (BMI) WITH 2-HOUR GLUCOSE TOLERANCE TEST (GTT) RESULTS AMONG OBESE WOMEN WITH POLYCYSTIC OVARIAN SYNDROME (PCOS). 
S. Nagy, M. Nam Menke, N. W. Karjane, D. W. Stovall. 

Back to the Top

REPRODUCTIVE HORMONES 

P-243 
PROSPECTIVE STUDY OF LACTATIONAL VASOMOTOR INSTABILITY EPISODES (VIE) WITH PALMAR SKIN CONDUCTANCE VALIDATION. 
S. Richman, A. Maheshwari, F. Naftolin. 

P-244 
ANTI-MULLERIAN HORMONE (AMH) AND IVF OUTCOMES. 
R. M. Riggs, T. D. Kimble, B. S. Leader, Z. Jie, L. A. Stadtmauer. 

P-245 
SERUM TSH: IS THERE A LINK BETWEEN SUBCLINICAL HYPOTHYROIDISM AND IVF OUTCOME. 
S. D. Spandorfer, P. Perez, O. K. Davis, Z. Rosenwaks. 

P-246 
LEPTIN DECREASES c-FOS EXPRESSION IN THE HYPOTHALAMUS OF THE CHICKEN EMBRYO. 
C. L. Casey, E. T. Zelazny, C. J. Forehand. 

P-247 
ELEVATIONS IN MATERNAL SERUM TESTOSTERONE IN EARLY PREGNANCY RELATED TO OVARIAN STIMULATION. 
R. B. Lathi, S. E. Moayeri, A. A. Milki, S. Potti, L. M. Westphall. 

P-248 
OBESITY: AN INDEPENDENT PROGNOSTIC FACTOR FOR THE DEVELOPMENT OF ENDOMETRIAL POLYPS IN INFERTILE PATIENTS. 
R. Onalan, G. Onalan, M. Dogan, L.Mollamahmutoglu. 

P-249 
TISSUE MICRO ARRAY AND EXPRESSION ANALYSIS OF COD­ING AND NATURAL ANTI-SENSE CALCITONIN GENE RELATED TRANSCRIPTS IN THE MOUSE ONTOGENY. 
A. H. Rezaeian, M. Yoshizawa, N. Hiraiwa, H. Yasue. 

Back to the Top

FEMALE REPRODUCTIVE TRACT 

P-250 
UNILATERAL TUBAL PATHOLOGY ON HYSTEROSALPINGOGRAPHY OR DIAGNOSTIC LAPAROSCOPY DOES NOT HAVE PROGNOSTIC SIGNIFICANCE FOR TREATMENT­INDEPENDENT PREGNANCY AT 12 MONTHS FOLLOW-UP. 
S. F. P. J. Coppus, P. Steures, J. W. van der Steeg, P. G. A. Hompes, F. van der Veen, B. W. J. Mol. 

P-251 
LOCATION OF THE ENDOMETRIAL POLYP AND ITS PREGNANCY RATE OF INFERTILITY PATIENTS. 
A. Yanaihara, T. Yorimitsu, H. Motoyama, T. Kawamura. 

P-252 
IN VIVO EXPRESSION OF TYPE I AND III COLLAGENS IN INJURED PERITONEUM THAT HEALED WITH ADHESIONS AND WITHOUT ADHESIONS. 
E. Elhammady, M. L. Freeman, M. P. Diamond, G. M. Saed. 

P-253 
"LIPOSALPINX": A NOVEL HUMAN FALLOPIAN TUBE DIS­EASE. CAN IT EXPLAIN A QUOTA OF UNEXPLAINED INFERTILITY CASES? 
M. A. Abdel-Aleem, A. F. Amin, M. A. M. Youssef, A. M. Makhlouf. 

P-254 
OBSTRUCTED HEMIVAGINA AND IPSILATERAL RENAL ANOMALY (OHVIRA) SYNDROME WITH A SINGLE SEPTATE UTERUS: FIRST CASE REPORT. 
J. Schantz-Dunn, M. R. Laufer. 

P-255 
UTERINE BLOOD FLOW CHANGE IN A RANDOMIZED DOUBLE­BLIND CLINICAL TRIAL OF A TRADITIONAL CHINESE HERBAL FORMULA TREATING PRIMARY DYSMENORRHEA. J.-Y. Liu, Y.-S. Liu, L. L. Liang Yeh, K.-S. Lin, T.-F. Tsai, L.-H. Wang. 

Back to the Top

ENDOMETRIUM 

P-256 
IDENTIFICATION OF HOXA10 TARGETS IN IMPLANTATION. 
D. Vitiello, R. Pinard, H. S. Taylor. 

P-257 
HYSTERECTOMY AFTER NOVASURE ENDOMETRIAL ABLATION: FAILURE OF A BRIDGE TO MENOPAUSE. 
A. L. Hsu, C. Bell, R. Burkman, D.Grow. 

P-258 
ENDOMETRIUM ADVANCEMENT IN CASE OF PREMATURE LUTEINIZATION IN GNRH ANTAGONIST CYCLES: CLEARLY PRESENT ON DAY 3 BUT ABSENT ON DAY 5. 
V. Vernaeve, C. Bourgain, S. Gonzalez, F. Lucco, C. Pozzobon, A. Ballesteros. 

P-259 
CDB-2914, A NOVEL SELECTIVE PROGESTERONE RECEPTOR MODULATOR, DIFFERENTIALLY REGULATES ENDOMETRIAL GENE EXPRESSION IN THE PROLIFERATIVE PHASE OF THE MENSTRUAL CYCLE. 
Q. Wei, E. D. Levens, L. K. Nieman. 

P-260 
COMPARING THE GENE EXPRES­SION PROFILE OF HUMAN ENDOMETRIAL CELLS BETWEEN DAY 2 (LH+2) AND DAY 7 (LH+7) AFTER THE LH SURGE, DURING NATURAL CYCLES OF WOMEN SCHEDULED FOR CONTROLLED OVARIAN STIMULATION. 
K. Terras, S. Gasca, F. Zhioua, T. Hfaiedh, L. Hamdoun, S. Hamamah. 

P-261 
CHARACTERIZING A PROLIFERATIVE PHASE ENDOMETRIAL DEFECT. 
T. S. Aldad, J. G. Bromer, H. S. Taylor. 

P-262 
THE ROLE OF BONE MORPHOGENETIC PROTEIN-7 (BMP-7) IN THE HUMAN ENDOMETRIUM. 
O. Yoshino, Y. Osuga, T. Yano, Y. Taketani. 

P-263 
CORRELATION BETWEEN LUTEAL SERUM PROGESTERONE LEVELS AND PREGNANCY IN OVULATION INDUCTION. 
D. R. Tredway, D. W. Warne, A. Eshkol, V. Alam. 

P-264 
SUBENDOMETRIAL VASCULARIZATION AND IN VITRO FERTILIZATION OUTCOMES. 
M. Scioscia, F. Lorusso, M. Palmisano, G. Serratì, G. Lamanna, R. Depalo.

P-265 
INDIAN HEDGEHOG AND ITS ASSOCIATED DOWN-STREAM TARGETS ARE ALTERED IN RESPONSE TO IN VIVO CDB-2914 ADMINISTRATION. 
E. D. Levens, Q. Wei, L. K. Nieman. 

P-266 
CYCLIC REGULATION OF TRANSCRIPTION FACTOR C/EBP IN HUMAN ENDOMETRIUM. 
B. J. Plante, M. K. Bagchi, L. Yuan, M. A. Fritz, S. L. Young. 

P-267 
ESTROGEN-RESPONSIVE GENE EXPRESSION IN THE ENDOMETRIUM. 
L. Li, K. Tatsumi, A. E. Hamilton, L. Aghajanova, K. C. Vo, L. C. Giudice. 

P-268 
EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-A AND ITS RECEPTOR-1 IN A LUTEAL ENDOMETRIUM IN PATIENTS WITH REPEATED IVF FAILURE. 
B. C. Jee, C. S. Suh, K. C. Kim, W. D. Lee, H. R. Kim, S. H. Kim. 

P-269 
CLINICAL UTILITY OF PCR IN THE DIAGNOSIS AND MANAGEMENT OF LATENT TUBERCULAR ENDOMETRITIS. 
S. Malik, S. Gupta, K. Makker, A. Agarwal, S. Nagpal. 

P-270 
GENE EXPRESSION VARIATIONS IN POST-LH SURGE ENDOMETRI­AL CELLS (DAY LH+2 AND LH+7) OF THE SAME PATIENTS BETWEEN NATURAL CYCLES AND CYCLES WITH OVARIAN HYPERSTIMULATION. 
K. Mahmoud, S. Gasca, C. Tikri, M. H. Ben Aribia, B. Hédon, S. Hamamah. 

P-271 
STEROID RECEPTOR EXPRESSION IN THE HUMAN ENDOMETRIUM DURING THE FOLLICULAR PHASE OF STIMULATED CYCLES. 
D. S. Kyrou, E. M. Kolibianakis, C. A. Venetis, D. Miliaras, J. Bontis, B. C. Tarlatzis. 

P-272 
THE EXPRESSION OF SPECIFIC GENES AND THEIR PREDICATED MICRO-RNA (MIRNA) IN HUMAN ENDOMETRIUM DURING THE WINDOW OF EMBRYO IMPLANTATION. 
X. Luo, T. Toloubeydokhti, Q. Pan, B. A. Ripps, N. Chegini.

P-273 
THE EFFECT OF OZONATED STERILE SALINE IRRIGATION ON THE ENDOMETRIUM OF FERTILE WOMEN. 
I. Calderon, M. Cohen, O. Artzi, J. Bachar, N. Lewit, G. Ohel. 

P-274 
EXPRESSION PROFILING OF AQUAPORIN (AQP) FAMILY IN NORMAL CYCLIC ENDOMETRI­UM AND THE ROLE OF AQPs IN THE OCCURRENCE OF ABNOR­MAL UTERINE BLEEDING (AUB). 
C. Feng, C.-C. Sun, H.-F. Huang. 

P-275 
GENETIC HETEROGENEITY UNDERLIES PATHOGENIC MECH­ANISMS IN ENDOMETRIAL POLYPS. 
Z. Liu, A. Niklaus, S. Pollack, N. Santoro, J. Pollard, L. Pal. 

P-276 
A CASE SERIES OF PATIENTS WITH ENDOMETRIAL INSUFFICIENCY TREATED WITH PENTOXIFYLLINE AND ALPHATOCOPHEROL. 
A. A. Okusami, M. E. Moore, J. M. Hurwitz, S. S. Richlin, M. P. Leondires. 

P-277 
CYCLIC CHANGES OF THE EXPRESSION OF STAR MRNA AND PROTEIN IN HUMAN ENDOMETRIUM. 
J. Li, Q. Liu, H. Xu, Y. Zeng, Y. Liang. 

P-278 
THE EFFECT OF ENDOMETRIAL GROWTH VELOCITY ON IVF-ET OUTCOME. 
J. Wang, L. Cong. 

Back to the Top

IMAGING 

P-279 
EVALUATION OF ANTRAL FOLLICLE GROWTH, SELECTION AND LUTEAL STRUCTURE-FUNCTION IN THE MACAQUE OVARY DURING THE MENSTRUAL CYCLE BY HIGH-RESOLUTION ULTRASONOGRAPHY. 
C. V. Bishop, M. L. Sparman, J. E. Stanley, M. B. Zelinski, R. L. Stouffer, A. Bahar. 

P-280 
THE PREVALENCE OF ENDOMETRIAL POLYPS AS DIAGNOSED BY SALINE INFUSION SONOHYSTEROGRAPHY AMONG DIFFERENT BODY MASS INDEXES. 
J. D. Parker. 

P-281 
EXTRUSION AND ABSORPTION OF FEMALE PRONUCLEAR PRECURSOR MAKES UNEVEN SIZED PRONUCLEI. 
K. Iwata, Y. Wakatsuki, T. Shimura, C. Takeshita, Y. Ueno, Y. Mio. 

P-282 
ASSESSMENT OF THE UTERINE CAVITY AND THE INTRAOSTIAL DISTANCE USING HYSTEROSALPINGOGRAPHY. 
J. G. Bromer, F. Sanguinetti, M. Tal, P. Patrizio. 

P-283 
THICKENED ENDOMETRIAL STRIPE IN WOMEN WITH POST­MENOPAUSAL BLEEDING: AN ASSOCIATION WITH A COMMON CONGENITAL UTERINE ANOMALY. 
M. H. Amols, S. A. El-Nashar, M. R. Hopkins, A. O. Famuyide. 

P-284 
THREE DIMENSIONAL ULTRASOUND (3D US): HIGH ACCURA­CY, LOW COST AND MINIMAL DISCOMFORT IN THE DIAGNOSIS OF UTERINE ANOMALIES. 
S. Bocca, E. Ragulin, L. Stadtmauer, A. Abuhamad, S. Oehninger. 

P-285 
DIAGNOSTIC AND THERAPEUTIC SIGNIFICANCE OF SELECTIVE SALPINGOGRAPHY IN WOMEN WITH TUBAL BLOCKAGE SUSPECTED BY HYSTEROSALPINGOGRAPHY. 
S. Furuya, M. Seki, Y. Fujisawa, T. Yamaguchi, H. Tobai, H. Kitagawa. 

P-286 WITHDRAWN 

P-287 
A COMPARATIVE STUDY OF 3­DIMENSIONAL SALINE INFUSION SONOGRAPHY (3DSIS) AND OFFICE HYSTEROSCOPY FOR THE DIAGNOSIS OF INTRACAVITARY PATHOLOGY PRIOR TO IN VITRO FERTILIZATION (IVF). PRELIMINARY REPORT. 
R. Marin-Medina, A. Morales-Martinez, M. Merino-Ruiz, L. Sordia-Hernandez, E. Gonzalez-Baez, R. Ambriz-Lopez. 

P-288 
RESPONSE OF IMMATURE AND MATURE MOUSE CYTOSKELETON TO ENDOMETRIOSIS - ROLE OF OXIDATIVE STRESS. 
G. Mansour, T. Falcone, A. E. Shahaat, R. Sharma, J. Goldberg, A. Agarwal. 

Back to the Top

ENDOMETRIOSIS 

P-289 
THE EXPRESSION PROFILE OF MICRO-RNA IN EUTOPIC AND ECTOPIC ENDOMETRIUM AND THE INFLUENCE OF OVARIAN STEROIDS ON THEIR EXPRESSION IN ENDOMETRIAL CELLS. 
Q. Pan, X. Luo, T. Toloubeydokhti, N. Chegini. 

P-290 
CURCUMIN SUPPRESSES ANGIOGENESIS, CELL PROLIFERATION AND INDUCES APOPTOSIS IN AN IN VITRO MODEL OF ENDOMETRIOSIS. 
F. Wieser, J. Yu, J. Park, N. Sidell, R. N. Taylor. 

P-291 
HIGH SERUM FOLLISTATIN LEVELS IN WOMEN WITH OVARIAN ENDOMETRIOSIS. 
P. Florio, F. M. Reis, P. B. Torres, C. Bocchi, F. Calonaci, F. Petraglia. 

P-292 
SMALL ENDOMETRIOTIC CYST­DOES IT HAVE ANY EFFECT ON IN VITRO FERTILIZATION (IVF) OUTCOME. 
T. Chacko, A. L. Ganesh, S. Sharma, S. K. Goswami, B. N. Chakroborty. 

P-293 
AN IN VIVO MODEL SUGGESTS THAT COLONY STIMULATING FACTOR-1 PLAYS A CRITICAL ROLE IN THE GENESIS OF THE EARLY ENDOMETRIOTIC LESION. 
J. R. Jensen, R. P. Perla, R. R. Tekmal, R. S. Schenken, C. A. Witz. 

P-294 
CORRELATION BETWEEN SPERM DNA DAMAGE, STAGE OF ENDOMETRIOSIS AND THE DURATION OF INFERTILITY. 
G. Mansour, J. Goldberg, A. Agarwal, R. Sharma, R. Mahfouz, T. Falcone. 

P-295 
FIBRINOLYTIC SYSTEM MULTIPLE GENE POLYMORPHISMS AND INITIATION OF ENDOMETRIOSIS: A NOVEL EVIDENCE. 
M. A. Bedaiwy, T. Falcone, E. Mascha, R. F. Casper. 

P-296 
SODIUM BUTYRATE (NaBu) DECREASES PROLIFERATION OF STROMAL CELLS DERIVED FROM ENDOMETRIOSIS AND ISHIKAWA CELLS IN CULTURE. 
A. Demiroglu-Zergeroglu, B. Pelin, R. Attar, E. Karatekelioglu, E. Attar, S. E. Bulun. 

P-297 
EFFECT OF MATRIX METALLO­PROTEINASE (MMP) INHIBITOR­DOXYCYCLINE ON THE INDUCTION OF ENDOMETRIOSIS IN AN EXPERIMENTAL RAT MODEL. 
H. B. Zeyneloglu, P. Akkaya, G. Onalan, P. Dursun. 

P-298 
EFFECT OF PEROXISOME PROLIFERATOR -ACTIVATED RECEPTOR-a (PPAR-a) AGONIST-FENOFIBRATE ON THE INDUCTION OF ENDOMETRIOSIS IN AN EXPERIMENTAL RAT MODEL. 
H. B. Zeyneloglu, G. Onalan, P. Akkaya, I. Kahraman, P. Dursun. 

P-299 
ENDOMETRIOSIS INDUCED ALTERATIONS IN THE MOUSE OOCYTE CYTOSKELETON. 
G. Mansour, R. Sharma, G. Lotfy, A. Agarwal, J. Goldberg, T. Falcone. 

P-300 
MATRIX METALLOPROTEINASE 7 EXPRESSION OF ENDOMETRIAL EPITHELIAL CELLS: A POTENTIAL MARKER FOR PATIENTS WITH DEEP INFILTRATING ENDOMETRIOSIS? 
S. Matsuzaki, M. Canis, J.-L. Pouly, G. Mage. 

P-301 
TENASCIN IS HIGHLY EXPRESSED IN ENDOMETRIOSIS AND ITS EXPRESSION IS UPREGULATED BY ESTROGEN. 
O. Tan, T. Ornek, Y. Seval, L. Sati, A. Arici. 

P-302 
S-NITROSYLATION OF CASPASE-3 IS THE MECHANISM BY WHICH ADHESION FIBROBLASTS MANIFEST LOWER APOPTOSIS. 
G. M. Saed, Z. L. Jiang, N. M.Fletcher, S. Galijasevic, M. P. Diamond, H. M. Abu-Soud. 

P-303 
THE EFFECT OF MONOCYTE CONDITIONED MEDIUM ON ESTROGEN AND PROGESTERONE REGULATION OF GENE EXPRESSION IN CULTURED ENDOMETRIAL STROMAL CELLS. 
K. M. Eyster, K. A. Hansen, O. Klinkova. 

P-304 
POSSIBLE AGGRAVATING IMPACT OF POLYCHLORINATED BIPHENYLS, PHTHALATE ESTERS AND GLUTATHIONE S-TRANSFERASE M1 GENE NULL POLYMORPHISM IN SOUTH INDIAN WOMEN WITH ENDOMETRIOSIS. 
R. Rozati.

P-305 
THE LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM (LNG-IUS) AND ENDOMETRIOSIS: MOLECULAR EFFECTS ON THE TOPIC AND ON THE ECTOPIC ENDOMETRIUM. 
M. K. O. Gomes, R. A. Ferriani, J. C. Rosa e Silva, A. C. J. S. Rosa e Silva, C. S. Vieira, S. B. Garcia. 

P-306 
THE OVULATION RATE OF DISEASED OVARIES DECREASED AFTER LAPAROSCOPIC CYSTECTOMY IN INFERTILE WOMEN WITH UNILATERAL ENDOMETRIOMA. 
T. Horikawa, K. Nakagawa, S. Ohgi, R. Kojima, M. Ito, H. Saito.

P-307 
MENSTRUAL ENDOMETRIAL CELLS FROM WOMEN WITH ENDOMETRIOSIS DEMONSTRATE INCREASED ADHERENCE TO PERITONEAL CELLS AND INCREASED EXPRESSION OF CD44 SPLICE VARIANTS. 
J. S. Griffith, Y.-G. Liu, P. A. Binkley, C. A. Witz, R. R. Tekmal, R. S. Schenken. 

P-308
AN ABNORMAL RESPONSE TO CRH STIMULATION IN CHRONIC PELVIC PAIN PATIENTS IS NOT EXPLAINED BY ANXIETY OR DEPRESSION.
B. J. Stegmann, J. A. Gemmill, J. Segars, G. Chrousos, P. Stratton.

P-309
REPRODUCTIVE HISTORY AND PREGNANCY OUTCOMES IN WOMEN WITH ENDOMETRIOSIS: FINDINGS FROM THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEYS (NHANES)
1999-2002.
E. Rillamas-Sun, A. D. Eyvazzadeh, D. I. Lebovic.

P-310
COMPARATIVE STUDY OF THE INFLUENCE OF THE LEVONORGESTREL INTRAUTERINE SYSTEM AND THE GNRH ANALOGUES ON CARDIOVASCULAR RISK MARKERS IN PATIENTS WITH ENDOMETRIOSIS.
C. S. Vieira, R. A. Ferreira, J. C. Rosa e Silva, A. C. J. S. Rosa e Silva, M. K. Gomes, R. A. Ferriani.

P-311
EXPRESSION OF HGF AND ITS RECEPTOR C-MET IN EUTOPIC AND ECTOPIC ENDOMETRIUM OF PATIENTS WITH ENDOMETRIOSIS.
J. Wu, F. He, G. Zhu.

P-312
INTERLEUKIN-17 STIMULATES THE PROLIFERATION AND IL-8 SECRETION FROM ENDOMETRIOTIC STROMAL CELLS.
T. Hirata, Y. Osuga, T. Yano, O. Tsutsumi, Y. Taketani.

P-313
DOES THE DURATION OF PELVIC SYMPTOMS PLAY A ROLE IN THE PREVALENCE OF INFERTILITY IN WOMEN WITH ENDOMETRIOSIS? 
S. Manipalviratn, P. Stratton, M. L. Ballweg, N. Sinaii.

P-314
DOES RADICAL LAPAROSCOPY (RLSC) FOR DEEP INVASIVE ENDOMETRIOSIS (DIE) IN INFERTILE WOMEN INCREASE OUTCOME OF IVF? RESULTS OF A PROSPECTIVE STUDY.
P. H. Bianchi, R. M. Pereira, A.Zanatta, E. L. Motta, G. D. Smith, P.C. Serafini.

P-315
PERITONEAL FLUID INTERLEUKIN (IL-8) IN PATIENTS WITH ENDOMETRIOSIS - IS THERE A CO-RELATION WITH SEVERITY  OR SYMPTOMS OF DISEASE? 
N. Malhotra, S. Gupta, A. Agarwal, V. Tripathi, K. K. Roy, S. Kumar. 

P-316
ASSOCIATION BETWEEN COMT GENE POLYMORPHISM AND ENDOMETRIOSIS-ASSOCIATED PAIN: AN INTERIM ANALYSIS. 
X. Xu, J. Ding, N. Rana, W. P. Dmowski.

P-317
IVF TREATMENT CANCELLATION FOLLOWING PROLONGED GNRH AGONIST FOR ENDOMETRIOSIS.
A. L. Gamelin, A. P. Cheung.

P-318
APPLICATION OF THE CICLOOXYGENASE-2 INHIBITOR, CELECOXIB, FOR THE TREATMENT OF ENDOMETRIOSIS: AN IN VITRO STUDY. 
C. N. Olivares, M. A. Bilotas, M. Borghi, C. Sueldo, M. Tesone, G. F. Meresman.

P-319
COMPREHENSIVE ANALYSIS OF GENE EXPRESSION ALTERATION IN RESPONSE TO GONADOTROPIN RELEASING HORMONE (GNRH) ANALOGUE IN ENDOMETRIOTIC STROMAL CELLS.
Y. Tanaka, K. Kato, H. Toh, K. Hashimoto, M. Nozaki, N. Wake.

P-320 
INCREASED CELL PROLIFERATION IN EXPERIMENTAL INDUCED ENDOMETRIOSIS IN RABBITS. 
M. F. Silva de Sa, J. C. Rosa e Silva, S. B. Garcia, A. C. J. S. Rosa e Silva, F. J. C. dos Reis, A. A. Nogueira. 

P-321 
SCOPE OF LEVONORGESTREL­RELEASING INTRAUTERINE SYSTEM (MIRENA) FOR SYMPTO­MATIC RELIEF AND UTERINE SIZE REDUCTION IN ADENOMYOSIS AND ASSOCIATED ENDOMETRIOSIS. 
M. Chakravarty, A. L. Ganesh, B. N. Chakravarty. 

P-322 
SURGICAL TREATMENT OF ENDOMETRIOSIS AND EMBRYO QUALITY. 
L. K. Shahine, R. O. Burney, A. A. Milki, L. M. Westphal, R. B. Lathi. 

P-323 WITHDRAWN 

P-324 
ARE IVF/ICSI OUTCOMES OF WOMEN WITH MINIMAL TO MILD ENDOMETRIOSIS ASSOCIATED INFERTILITY COMPARABLE TO THOSE WITH UNEXPLAINED INFERTILITY? 
H. O. Kim, K. M. Yang, J. Y. Kim, I. O. Song, I. S. Kang, M. K. Koong.

P-325 
GENES DOWN REGULATED IN WOMEN WITH ENDOMETRIOSIS OBTAINED BY RAPID SUBTRACTION HYBRIDIZATION (RaSH). 
R. A. Ferriani, J. Meola, D. B. Dentillo, J. C. Rosa e Silva, W. A. Silva, Jr, L. Martelli. 

P-326 
ENDOMETRIOMA AND OOCYTE RETRIEVAL-INDUCED PELVIC ABSCESS: A CLINICAL CONCERN OR AN EXCEPTIONAL COMPLICATION? 
E. Somigliana, L. Benaglia, R. Iemmello, E. Colpi, A. E. Nicolosi, G. Ragni. 

Back to the Top

LEIOMYOMA 

P-327 
THE INHIBITING EFFECT OF METFORMIN ON THE EXPRESSION OF ENDOMETRIAL LEUKAEMIA­INHIBITORY FACTOR AND LEPTIN DURING IMPLANTATION IN recFSH STIMULATED CYCLES OF HYPERANDROGENIC RATS (ENVIRONMENT PCOS). 
C. Kaya, T. Ornek, Y. Seval, R. Pabuccu, G. Onalan, N. Demir. 

P-328 
MYOMETRIAL CELLS UNDERGO FIBROTIC TRANSFORMATION UNDER THE INFLUENCE OF TRANSFORMING GROWTH FAC­TOR BETA 3. 
D. Joseph, M. Malik, J. Norian, J.Webb, W. Catherino. 

P-329 
CURCUMIN, A NUTRITIONAL SUPPLEMENT WITH ANTINEOPLASTIC ACTIVITY, SELECTIVELY INHIBITS LEIOMYOMA GROWTH. 
M. Malik, J. Britten, P. Driggers, M. Payson, J. H. Segars, W. H. Catherino. 

P-330 
PROFILE OF DIFFERENTIALLY EXPRESSED GENES AND THEIR PREDICATED MICRO-RNA (miRNA) IN LEIOMYOMAS AND MYOMETRIUM. 
X. Luo, Q. Pan, N. Chegini.

P-331 
SODIUM BUTYRATE (NABU) INHIBITS PROLIFERATION OF CO25 MYOBLAST CELLS BEARING A HUMAN STEROID­INDUCIBLE N-RAS ONCOGENE. 
A. Demiroglu-Zergeroglu, P. Balcik, R. Attar, B. Basara, H. Cemal, E. Attar. 

P-332 
ALL-TRANS RETINOIC ACID REGULATES COLLAGEN SYNTHESIS IN HUMAN UTERINE LEIOMYOMAS. 
J. L. Britten, M. Malik, M. Payson, J.Norian, D. Joseph, W. H. Catherino. 

P-333 
LEIOMYOMAS FROM HEREDI­TARY LEIOMYOMATOSIS AND RENAL CELL CANCER (HLRCC) ARE HIGHLY DEPENDENT UPON GLYCOLYSIS FOR ENERGY HOMEOSTASIS. 
K. M. Vanevski, M. Malik, D. Joseph, M. Payson, W. H. Catherino. 

P-334 
STIFFNESS MATTERS: MECHANICAL PROPERTIES OF HUMAN LEIOMYOMAS AND THEIR EXTRACELLULAR MATRIX COMPOSITION. 
J. Norian, G. Christman, C. Korecki, J.Iatridis, F. Chen, J. Segars. 

P-335 
EVALUATION OF BONE MINERAL DENSITY IN AFRICAN AMERICAN WOMEN WITH UTERINE LEIOMYOMA: A CROSS SECTIONAL STUDY. 
O. Muneyyirci-Delale, F. Nessim, J. Karam, N. Osei-Tutu, D. Mathur, S. McFarlane. 

P-336 
RECRUITMENT AND RETENTION OF SUBJECTS FOR CLINICAL LEIOMYOMA TRIALS. 
D. McCarthy-Keith, W. Blocker, E. Levens, L. Nieman, A. Armstrong. 

Back to the Top

FEMALE REPRODUCTIVE SURGERY 

P-337 
EFFECTS OF SILYMARIN ON POSTOPERATIVE PERITONEAL ADHESIONS AND CYTOKINE EXPRESSION IN A RAT MODEL. 
K. Mousavizadeh, B. Jameie.

P-338 
SUCCESSFUL ENGINEERING MOUSE UTERINE TISSUE BY IN VIVO IMPLANTATION OF BIODEGRADABLE COLLAGEN MATRIX. 
H.-C. Liu, Z. He, Y. Tang, W. Wang, Z. Rosenwaks. 

P-339 
SUCCESSFUL TREATMENT OF IATROGENIC COMPLETE CERVICAL OCCLUSION WITH AN INNOVATIVE USE OF A MULTIPURPOSE DRAINAGE CATHETER. 
J. A. Cunkelman, L. Lawrence, R. Odem. 

P-340 
RISK FACTORS FOR POST-OPERATIVE INTRAUTERINE ADHESIONS AFTER MYOMECTOMY. 
J. L. Kulp, D. V. Makarov, J. Garcia, C. Lipari.

P-341 
A COST-EFFECTIVENESS ANALYSIS OF ADHESION BARRIERS IN PREVENTING SMALL BOWEL OBSTRUCTION AFTER TOTAL ABDOMINAL HYSTERECTOMY. 
R. Alvero, S. Wang, D. Smith. 

P-342 
A STUDY ABOUT THE TREATMENT OUTCOME OF ENDOMETRIAL HYPERPLASIA BY LETROZOLE AS A PRIMARY THERAPY IN YOUNG WOMEN. 
H. Li, X. Chen, J. Qiao.

P-343 
CONSERVATIVE TREATMENT OF UTERINE ADENOMYOSIS IN THE INFERTILE WOMEN WITH COMBINED PREOPERATIVE GONADOTROPIN-RELEASING HORMONE AGONIST THERAPY AND CYTOREDUCTIVE SURGERY. 
C.-S. Shiau, C.-C. Hsieh, M.-Y. Chang, C.-L. Hsieh, T.-T. Hsieh. 

P-344 
PRIMATE UTERUS ALLOGRAFT TRANSPLANTATION. 
G. Del Priore, S. Schlatt, R. Wagner, J. R. Smith, J. Stega.

P-345 
PHYSICIAN AND NURSE ACCURACY OF ESTIMATING BLOOD LOSS. 
S. Tsirkin, D. Gudipudi, R. Wong, N. Montemarano, G. Del Priore, E. Grinfeld. 
(SRS In-Training Award for Research) 

P-346 
FOR PUBLICATIONS IN FERTILITY & STERILITY, QUALITY CLINICAL RESEARCH HAS SHIFTED ABROAD. 
J. Peterson, B. S. Minhas, B. A. Ripps. 

P-347 
MAYER-ROKITANSKY-KUSTER-HAUSER (MRKH) SYNDROME WITH MÜLLERIAN REMNANTS: AN ARGUMENT FOR "MÜLLERIAN DYSGENESIS" RATHER THAN "AGENESIS". 
D. Lee, T. Gregory, K. Burry, M. Gorrill, P. Patton. 

P-348 
HOW IMPORTANT IS THE METHOD OF TUBAL STERILIZATION IN THE OUTCOME AFTER TUBAL ANASTOMOSIS? 
S. Gordts, R. Campo, P. Puttemans, S. Gordts. 

P-349 
IMMUNOSUPPRESSION IN ALLOGRAFT PRIMATE UTERINE TRANSPLANTATION. 
D. Gudipudi, G. Del Priore, S. Schlatt, N. Montemarano, J. Stega.

P-350 
ROUTINE EXCISION OF POSTERIOR VAGINAL FORNIX IS NECESSARY IN THE SURGICAL MANAGE­MENT OF PATIENTS WITH DEEP INFILTRATING ENDOMETRIOTIC NODULES OF MORE THAN 2 CM IN SIZE. 
S. Matsuzaki, C. Houlle, K. Jardon, J.-L. Pouly, G. Mage, M. Canis. 

P-351 
BENEFITS OF PREVENTIVE TRANSHYSTEROSCOPIC METROPLASTY (THM) IN SEPTATE UTERUS. 
R. C. Inza, L. Ponte, A. Kenny, G. Van Thillo, E. Lombardi, G. Marconi. 

P-352 
EARLY SECOND-LOOK FLEXIBLE HYSTEROSCOPY IS EFFECTIVE FOR THE TREATMENT OF ASHERMAN'S SYNDROME. 
T. Fumino, A. Teranishi, E. Wakimoto, H. Hamai, A. Kuwata, M. Shigeta. 

P-353 
CONSERVATIVE MANAGEMENT OF ADNEXAL TORSION VIA TRANSVAGINAL ULTRASOUND GUIDED OVARIAN CYST ASPIRATION IN PATIENTS WITH OVARIAN HYPERSTIMULATION. 
W. Zhu, X. Li, X. Chen, Z. Fu.
(SRS In-Training Award for Research) 

P-354 
POTENTIAL CANDIDATES FOR UTERINE TRANSPLANTATION: AN ASSESSMENT OF NEED. 
A. R. Nair, N. Montemarano, D. Gudipudi, J. Stega, J. R. Smith, G. DelPriore. 
(SRS In-Training Award for Research) 

P-355 
SIMPLIFIED LAPAROSCOPIC CERCLAGE IN 7 IVF PREGNANCIES. 
M. D. Tsirigotis, T. N. Dimitriades. 

P-356 
LAPAROSCOPIC CREATION OF NEOVAGINA USING MOBILIZED PERITONEUM IN A PATIENT WITH MAYER-ROKITANSKY-KUSTER-HAUSER SYNDROME. 
A. F. Rechkemmer. 

P-357 
PERFUSION INDEX, PULSE OXYMETRY AND DOPPLER FLOW STUDIES TO FACILITATE UTERINE TRANSPLANTATION. 
E. Y. Kuzmin, A. David, H. Simon, I. Lindsay, D. Noakes, R. J. Smith. 

Back to the Top

PREGNANCY LOSS AND TERMINATION 

P-358 
CYTOGENETIC STUDY AND ULTRASONOGRAPHIC FINDINGS IN SPONTANEOUS ABORTIONS ­COMPARISON BETWEEN PREGNANCIES OCCURRING AFTER ART AND SPONTANEOUS OVULATORY CYCLES. 
Y. Fujisawa, S. Furuya, M. Seki, T. Yamaguchi, H. Tobai, H. Kitagawa. 

P-359 
ROLE OF COMBINATION OF LOW DOSE LOW MOLECULAR WEIGHT HEPARIN AND ASPIRIN IN TREATING UNEXPLAINED RECURRENT MISCARRIAGE. 
S. Sharma, A. L. Ganesh, S. K. Goswami, B. N. Chakravarty. 

P-360 
LOW DOSE ASPIRIN RESCUES SUBSEQUENT PREGNANCIES OF THE PATIENTS WITH TWO CONSECUTIVE MISCARRIAGES ASSOCIATED WITH ANTIPHOSPHO­LIPID ANTIBODIES AND/OR HYPERCOAGULABILITY. 
H. Gohou, Y. Nakaoka, K. Sugihara, F. Nagata, A. Fukuda, Y. Morimoto. 

Back to the Top

REPRODUCTIVE IMMUNOLOGY 

P-361 
SIGNIFICANCE OF SOLUBLE HLA-G DETECTION IN FOLLICULAR FLUIDS AND EMBRYO SUPERNATANTS IN IVF/ICSI CYCLES. 
N. Ledee, R. Lombroso, S. Perrier­hauterive, F. Thonon, P. Le bouteiller, J. Tabiasco. 

P-362 
ASSOCIATION BETWEEN ANTIPHOSPHOLIPID ANTIBODIES AND RECURRENT EARLY PREGNANCY LOSS - A SYNDROME ACTUALLY EXISTS! 
W. H. Kutteh, R. W. Ke, C. R. Jaslow. 

P-363 WITHDRAWN 

P-364 
ENDOMETRIAL EXPRESSION OF INTERLEUKINE RECEPTOR ANTAGONIST (IL-1RA) IS ALTERED DURING IRREGULAR BLEEDING IN PROGESTIN-ONLY CONTRACEPTIVE USERS AND INFLUENCED BY DOXYCYCLINE THERAPY. 
N. Chegini, X. Luo, K. Johnson, A. Rhoton-Vlasak, D. F. Archre. 

P-365 
PARVOVIRUS B-19 ASSOCIATED HEMOPHAGOCYTIC REACTIVE SYNDROME DURING PREGNANCY. 
O. Duenas, S. Gupta, H. Rico, A. Agarwal. 

P-366 
UTILITY OF QUANTIFERON GOLD TEST TO CORROBORATE THE DIAGNOSIS OF LATENT TUBERCULAR ENDOMETRITIS. 
S. Malik, S. Gupta, K. Makker, R. Sharma, V. Prakash, A. Agarwal. 

P-367 
NEW INSIGHTS INTO IMMUNOLOGICAL INFERTILITY: TESTING FOR ANTISPERM ANTIBODIES AND SPERM-ZONA PELLUCIDA BINDING ABILITY BY THE IMMUNOBEAD ASSAY AND SPERM-HYALURONIC ACID INTERACTION. 
A. Yagci, F. Sanguineti, J. Stronk, R. Bronson, P. Patrizio, G. Huszar. 

P-368 
CLINICAL OBSERVATION OF XIAOKANGDIHUANG TANG IN TREATING THE PATIENTS OF ANTICARDIOLIPIN ANTIBODY­POSITIVE. 
X. Zhan, Z. Feng, L. Mao, R. Cai, Y. Lai. 

Back to the Top

PREIMPLANTATION GENETIC DIAGNOSIS 

P-369 
DOES DEVELOPMENT TO THE BLASTOCYST STAGE CORRELATE WITH EUPLOIDY? 
J. L. Eaton, M. R. Hacker, D. Harris, K. Thornton, A. Penzias. 

P-370 
INCREASED INCIDENCE OF MOSAIC EMBRYOS WITH THE MICROINJECTION OF SPERMATOZOA WITH ABNORMAL MOR­PHOLOGY. 
A. Delgado, M. De Los Santos, P. Buendia, C. Simon, J. Remohi, A. Pellicer. 

P-371
USE OF THE COMET ASSAY™ TO DETERMINE DNA INTEGRITY IN SINGLE CELLS FOLLOWING LASER ASSISTED HATCHING AND BIOPSY IN A MURINE MODEL.
D. L. Walker, J. R. Fredrickson, C. C. Coddington III, D. Morbeck.

P-372
THE PERCENTAGE OF ABNORMAL EMBRYOS BY PGD-AS NEGATIVELY CORRELATES WITH IVF SUCCESS RATE IN YOUNG PATIENTS.
J. Q. Huang, P. H. Chung, K. Xu, Z. Rosenwaks.

P-373
DOES EMBRYO MORPHOLOGY PREDICT PLOIDY? AN UPDATE ON THE USEFULNESS OF PGD TESTING FOR ANEUPLOIDY. 
E. Fino, S. Talebian, J. Grifo, C. McCaffrey, A. Adler, N. Noyes.

P-374
SINGLE CELL WHOLE GENOME AMPLIFICATION TECHNIQUE SIGNIFICANTLY IMPACTS THE ACCURACY AND PRECISION OF MICROARRAY BASED 23 CHROMOSOME ANEUPLOIDY SCREENING. 
N. R. Treff, J. Su, X. Tao, J. Mavrianos, R. T. Scott, Jr.

P-375
TO PGD OR NOT TO PGD: IS THERE A MAGIC NUMBER OF OOCYTES TO START WITH?
I. Tur-Kaspa, A. Bernal, N. Tkachenko, J. Pawlovska, S. Rechitsky, Y.Verlinsky.

P-376
COMPARISON OF EMBRYONIC ANEUPLOIDY RATES IN YOUNG (<35 YEARS) INFERTILE PATIENTS FOLLOWING THREE DIFFERENT OVARIAN STIMULATION PROTOCOLS.
Z. P. Nagy, T. Elliott, T. Callaghan, G. Wright, D. Shapiro, D. Mitchell-Leef.

P-377
INCREASED EUPLOID EMBRYOS AFTER SUPPLEMENTATION WITH DEHYDROEPIANDROSTERONE (DHEA) IN WOMEN WITH PREMATURE OVARIAN AGING.
N. Gleicher, A. Weghofer, D. Barad. 

P-378
ANEUPLOIDY RATE ACCORDING TO CELL STAGE AT EMBRYO BIOPSY.
G. Harton, M. Reeves, A. Dorfmann, E. Duran, K. Redford, H. Stern.

P-379
PREIMPLANTATION GENETIC DIAGNOSIS OF X-LINKED RETINOSCHISIS USING MULTIPLE DISPLACEMENT AMPLIFICATION (MDA).
R. Morales, B. Lledo, J. A. Ortiz, J. Guerrero, J. Llacer, R. Bernabeu.

P-380
PREIMPLANTATION GENETIC DIAGNOSIS OF X-LINKED ADRENOLEUKODYSTROPHY (ALD) WITH GENDER DETERMINATION USING MULTIPLE DISPLACEMENT AMPLIFICATION.
J. Llacer, B. Lledo, J. A. Ortiz, A. Rodriguez, R. Morales, R. Bernabeu.

P-381
PREIMPLANTATION GENETIC DIAGNOSIS-ANEUPLOIDY SCREENING (PGD-AS) INCREASES CLINICAL PREGNANCY RATES WITH REDUCED NUMBERS OF EMBRYOS TRANSFERRED IN WOMEN FORTY-TWO YEARS OF AGE AND OLDER.
C. M. Briton-Jones, M. Surrey, H. Danzer, D. L. Hill.

P-382
GENETIC STATUS OF BLASTOMERES REMAINING INSIDE OF THE EMPTY ZONA PELLUCIDA (EZP) AFTER HATCHING.
B. R. Behr, J. R. Nelson, B. A. Kolb, J. G. Wilcox, T. Tan, V. N. Ivakhnenko.

P-383 
CORRELATION BETWEEN PREIMPLANTATION GENETIC DIAGNOSIS RESULTS AND SOLUBLE HLA G CONCENTRATIONS IN EMBRYO CULTURE MEDIA. 
C. B. Coulam, R. G. Roussev, S. Lerner, Y. Verlinsky, I. Tur-Kaspa. 

P-384 
DEVELOPING A SINGLE CELL OLIGONUCLEOTIDE ARRAY-CGH TEST FOR ANEUPLOID SCREENING. 
J. B. Spencer, W. Shang, W. Sun, D. R. Session, D. H. Ledbetter, C. Lese Martin. 

P-385 
HIGH LEVEL OF CHROMOSOME ANEUPLOIDY IN THE SPERMATOZOA OF MAN WITH SEVERE OLIGOASTHENOTERATOZOOSPERMIA (OAT): CASE REPORT. 
S. A. S. Fonseca, C. C. Rocha, V. S. Pereira, J. Cardoso, R. Abdelmassih, S. Abdelmassih. 

P-386 
DOES IVF WITH PGD AND BLASTOCYST TRANSFER AFFECT OFFSPRING'S SEX-RATIO? 
I. Tur-Kaspa, N. Katz, I. Kuznyetsova, Y. Verlinsky. 

P-387 
EMBRYO CULTURE TO THE BLASTOCYST STAGE DOES NOT SELECT FOR GENDER. 
J. L. Eaton, M. R. Hacker, D. Harris, K. Thornton, A. Penzias. 

P-388 
BLASTOCYST TROPHECTODERM BIOPSY: A CASE STUDY. 
A. R. Anderson, K. J. Graff, J. L. Crain. 

P-389 
MULTIPLE DISPLACEMENT AMPLIFICATION (MDA) A NEW APPROACH FOR PREIMPLANTATION GENETIC DIAGNOSIS (PGD): OUR EXPERIENCE. 
J. Llacer, B. Lledo, R. Morales, A. Rodriguez, J. Ten, R. Bernabeu. 

P-390 WITHDRAWN 

P-391 
COMPARISON OF SPERM CHROMOSOMAL ABNORMALITIES AND PREIMPLANTATION GENETIC DIAGNOSIS OUTCOME IN PATIENTS WITH EXTREME MALE FACTOR. 
M. L. Lenzi, S. Silber, P. Colls, X. Zheng, J. Cohen, S. Munne. 

P-392 
AN EFFICIENT AND RELIABLE DNA EXTRACTION METHOD FOR PREIMPLANTATION GENETIC DIAGNOSIS: A COMPARISON OF ALLELE DROP-OUT AND AMPLIFICATION RATE USING DIFFERENT SINGLE CELL LYSIS METHODS. 
S. Kim, J. Yoon, S. Chae, Y. Choi, S. Kim, S. Moon. 

P-393 
COMPREHENSIVE GENETIC ANALYSES USING A MODIFIED WHOLE GENOME AMPLIFICATION PROTOCOL AND MICROARRAYS TO IDENTIFY GENETIC DISORDERS AND DETERMINE EMBRYO IMPLANTATION FROM SINGLE CELLS. 
W. G. Kearns, R. Pen, A. Benner, E. Widra, R. Leach. 

P-394 
A RETROSPECTIVE ANALYSIS OF FISH "NORMAL" BLASTOMERES IN FAILED PGD CYCLES: A PRELIMINARY REPORT. 
L. Keskintepe, G. Sher, M. Ginsburg, M. Keskintepe, P. Okamoto, J. Crowley. 

P-395 
PREIMPLANTATION GENETIC SCREENING (PGS) FOR ANEUPLOIDY IN EMBRYOS AFTER IN VITRO FERTILIZATION (IVF) DOES NOT IMPROVE REPRODUCTIVE OUTCOME IN WOMEN OVER 35: A PROSPECTIVE CONTROLLED RANDOMIZED STUDY. 
S. Debrock, C. Melotte, J. Vermeesch, C. Spiessens, E. Vanneste, T. M. D'Hooghe. 

P-396 
A COST-BENEFIT ANALYSIS OF PREIMPLANTATION GENETIC DIAGNOSIS FOR CARRIER COU­PLES OF CYSTIC FIBROSIS. 
L. B. Davis, S. J. Champion, S. O.Fair, L. M. Aquino, P. M. Blanchfield, A. M. Garber. 

P-397 
PREIMPLANTATION GENETIC DIAGNOSIS OF SICKLE-CELL/C ß GLOBIN MUTATIONS USING A SINGLE BASE EXTENSION GENO­TYPING ASSAY. 
B. D. Mariani, B. W. Meltzer, M. J. Reeves, G. L. Harton, H. J. Stern. 

P-398 
SHOULD PREIMPLANTATION GENETIC DIAGNOSIS FOR ANEUPLOIDY SCREENING BE USED FOR POOR PROGNOSIS PATIENTS? 
A. Finn, T. F. O'Leary, K. M. Delegge, R. I. Hardy, L. A. Scott, J. A. Hill. 

P-399 
PREIMPLANTATION GENETIC SCREENING (PGS) FOR ANEUPLOIDY IN COUPLES UNDERGOING DONOR EGG IN VITRO FERTILIZATION CYCLES. 
R. Pen, A. Benner, P. Browne, W. G. Kearns. 

P-400 
COMPLEX CHROMOSOME ABNORMALITY IN PATIENTS WITH IN VITRO FERTILIZATION (IVF) AND INTRACYTOPLASMIC SPERM INJECTION (ICSI). 
S. P. Weng, T. C. J. Wu, S. P. Kang, M. W. Surrey, H. C. Danzer, D. L. Hill. 

P-401 
PGD FOR ANEUPLOIDY: US IVF CLINICS' PRACTICE AND POLICY. 
S. Baruch, D. Kaufman, K. L. Hudson.

P-402 
PREIMPLANTATION GENETIC DIAGNOSIS IN A CASE OF RECURRENT TRISOMY 21 OFFSPRING. 
S. B. A. Hudson, D. L. Walker, J. R. Fredrickson, D. E. Morbeck, C. C. Coddington, R. P. Gada. 

Back to the Top

GENETIC COUNSELING 

P-403 
INTERCHROMOSOMAL EFFECTS IN SPERM OF THREE HETEROZYGOUS CARRIERS OF STRUCTURAL CHROMOSOMAL REARRANGEMENTS. 
G. Kirkpatrick, E. Chan Wang, K. Ferguson, S. Ma. 

P-404 
REPRODUCTIVE GENETIC COUNSELING IN PATIENTS WITH COMPLEX CHROMOSOMAL REARRANGEMENT. 
N. Takeshita, Y. Katagiri, Y. Shibui, M. Kitamura, Y. Fukuda, M. Morita. 

P-405 
IMPLANTATION AND PREGNAN­CY RATES AFTER PREIMPLAN-TATION GENETIC SCREENING (PGS) TESTING IN FIRST-CYCLE IN VITRO FERTIL